Skip to content

Retractions and corrections in psychedelic and consciousness research

The library holds 28 retracted papers, 2 under an expression of concern, 452 with a published correction, and 117 discussed on PubPeer. Retracted papers stay in the library, labeled, because hiding them would leave the citations pointing at nothing.

Still cited after retraction 22

Retracted papers that papers in the library cited after the retraction notice was published. A citation is not always reliance: some papers cite a retraction to discuss it, and a paper published soon after a notice may have been written before it. Only citations between papers in the library are counted, so the true totals are higher.

22 of the library's 28 retracted papers have been cited by papers published after their retraction: 283 citations in all.

  1. Standardised Mindfulness-Based Interventions in Healthcare: An Overview of Systematic Reviews and Meta-Analyses of RCTs

    Retracted April 2019 Cited 68 times since Retraction notice (opens in new tab)

    Show the 68 citing papers
    1. Mindfulness intervention for foundation year doctors: a feasibility study. Pilot and Feasibility Studies · April 27, 2019
    2. Conducting a pilot randomized controlled trial of community-based mindfulness-based stress reduction versus usual care for moderate-to-severe migraine: protocol for the Mindfulness and Migraine Study (M&M). Trials · May 6, 2019
    3. Theoretical Foundations to Guide Mindfulness Meditation: A Path to Wisdom June 1, 2019
    4. Mindfulness-Based Coping With University Life: A Randomized Wait-List Controlled Study Sage Open · June 14, 2019
    5. Effects of Mindfulness Yoga vs Stretching and Resistance Training Exercises on Anxiety and Depression for People With Parkinson Disease: A Randomized Clinical Trial. JAMA Neurology · July 1, 2019
    6. Deficient Emotional Self-Regulation in Children with Attention Deficit Hyperactivity Disorder: Mindfulness as a Useful Treatment Modality. Journal of Developmental and Behavioral Pediatrics · July 1, 2019
    7. Mindfulness-based social cognition training (SocialMIND) versus psychoeducational multicomponent intervention for people with a first episode of psychosis: a study protocol for a randomised controlled trial. BMC Psychiatry · July 29, 2019
    8. Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects. Neuroimage · August 1, 2019
    9. Loving-kindness meditation slows biological aging in novices: Evidence from a 12-week randomized controlled trial. Psychoneuroendocrinology · October 1, 2019
    10. Psychological Theories of Meditation in Early Buddhism and Sāṃkhya/Yoga The Oxford Handbook of Meditation · October 4, 2019
    11. Attachment-based compassion therapy and adapted mindfulness-based stress reduction for the treatment of depressive, anxious and adjustment disorders in mental health settings: a randomised controlled clinical trial protocol. BMJ Open · October 8, 2019
    12. Effects of a mindfulness based childbirth and parenting program on pregnant women's perceived stress and risk of perinatal depression-Results from a randomized controlled trial. Journal of Affective Disorders · October 30, 2019
    13. The Efficacy of the Mobile Application-Based Mindfulness Mediation on Adjustment of College Students in Hong Kong: A Randomized Controlled Trial Learning Environment and Design · 2020
    14. Mindfulness, Anxiety Symptoms, and Quality of Life in Heart Failure. The Journal of cardiovascular nursing · 2020
    15. Mindfulness‐based stress reduction improves irritable bowel syndrome (IBS) symptoms via specific aspects of mindfulness Neurogastroenterology & Motility · April 7, 2020
    16. Effects of Mindfulness Meditation on Self-Transcendent States: Perceived Body Boundaries and Spatial Frames of Reference. Mindfulness · May 1, 2020
    17. Mindfulness-based cognitive therapy for bipolar disorder: A systematic review and meta-analysis. Psychiatry Research · May 25, 2020
    18. The Effectiveness of Mindfulness-Based Interventions on Anxiety Disorders. A Systematic Meta-Review European Journal of Investigation in Health, Psychology and Education · July 14, 2020
    19. Changes in the neural correlates of self-blame following mindfulness-based cognitive therapy in remitted depressed participants. Psychiatry Research Neuroimaging · July 23, 2020
    20. Increased Interest for Mindfulness Online. International Journal of Yoga · September 13, 2020
    21. Feasibility and Acceptability of a Community-Based Modified Mindfulness-Based Stress Reduction Program for the Under- and Unemployed Global Advances in Health and Medicine · November 10, 2020
    22. Development of a mindfulness-based treatment for smoking cessation and the modification of alcohol use: A protocol for a randomized controlled trial and pilot study findings. Contemporary Clinical Trials · November 14, 2020
    23. Mindfulness-Based Cognitive Therapy for Unmedicated Obsessive-Compulsive Disorder: A Randomized Controlled Trial With 6-Month Follow-Up. Frontiers in Psychiatry · 2021
    24. Not all types of meditation are the same: Mediators of change in mindfulness and compassion meditation interventions. Journal of Affective Disorders · February 2, 2021
    25. The Empirical Status of Mindfulness-Based Interventions: A Systematic Review of 44 Meta-Analyses of Randomized Controlled Trials Perspectives on Psychological Science · February 16, 2021
    26. Mindfulness-based interventions for social anxiety disorder: A systematic review and meta-analysis. Psychiatry Research · April 20, 2021
    27. Changes in Perceived Stress Following a 10-Week Digital Mindfulness-Based Stress Reduction Program: Retrospective Study JMIR Formative Research · May 25, 2021
    28. Impact of Mindfulness-Based Cognitive Therapy on Depressive Symptoms Reduction among Depressed Patients in Nigeria: A Randomized Controlled Trial. Issues in Mental Health Nursing · July 2021
    29. Effectiveness of Mindfulness Meditation Programs in the Promotion of Quality of Life in Patients with Heart Failure: A Systematic Review International Journal of Cardiovascular Sciences · July 29, 2021
    30. Mindfulness Based Therapy in Cancer Patients: Meta-Analysis Asian Pacific Journal of Cancer Care · August 27, 2021
    31. A mindfulness meditation mobile app improves depression and anxiety in adults with sleep disturbance: Analysis from a randomized controlled trial General Hospital Psychiatry · September 11, 2021
    32. 3-Doors Compassion Project: Examining the longitudinal effects of a nine-month Tibetan mind-body meditation program Current Psychology · September 28, 2021
    33. A systematic review and meta-analysis of acceptance- and mindfulness-based interventions for DSM-5 anxiety disorders Scientific Reports · October 14, 2021
    34. Exploring the Effects of Meditation Techniques Used by Mindfulness-Based Programs on the Cognitive, Social-Emotional, and Academic Skills of Children: A Systematic Review. Frontiers in Psychology · November 12, 2021
    35. Heal the Healers: A pilot study evaluating the feasibility, acceptability, and exploratory efficacy of a Transcendental Meditation intervention for emergency clinicians during the coronavirus disease 2019 pandemic. Journal of the American College of Emergency Physicians Open · December 1, 2021
    36. Effects of MBSR therapy on negative emotions, fatigue, and sleep quality in “post-ICU patients” Medicine · January 7, 2022
    37. Mindfulness-Based Interventions and Body Awareness Brain Science · February 1, 2022
    38. Predictors and moderators of outcomes in mindfulness-based cognitive therapy intervention for early breast cancer patients. Palliative & Supportive Care · April 2022
    39. Mindfulness-Based Smoking Cessation Delivered Through Telehealth and Text Messaging for Low-Income Smokers: Protocol for a Randomized Controlled Trial JMIR Research Protocols · August 1, 2022
    40. Effectiveness of mindfulness-based cognitive therapy against suicidal ideation in patients with depression: A systematic review and meta-analysis. Journal of Affective Disorders · September 1, 2022
    41. Effect of mindfulness meditation on depression during pregnancy: A meta-analysis Frontiers in Psychology · September 14, 2022
    42. The role of mindfulness training in sustaining weight reduction: retrospective cohort analysis. BJPsych Open · November 15, 2022
    43. Online, low-volume meditation does not alter immune-related biomarkers. Brain, Behavior, & Immunity - Health · December 2022
    44. Mindfulness-based stress reduction for men on active surveillance for prostate cancer and their spouses: Design and methodology of a randomized controlled trial. Contemporary Clinical Trials · February 2023
    45. Comparative effectiveness of a mindfulness-based intervention (M-Body) on depressive symptoms: study protocol of a randomized controlled trial in a Federally Qualified Health Center (FQHC). Trials · February 17, 2023
    46. The effect of mindfulness therapy in acromegaly, a pilot study. Clinical endocrinology · March 1, 2023
    47. Mindfulness in sex therapy and intimate relationships: a feasibility and randomized controlled pilot study in a cross-diagnostic group. Sexual Medicine · June 1, 2023
    48. Rolling out a mindfulness-based stress reduction intervention for parents of children with ADHD: a feasibility study Irish Journal of Psychological Medicine · June 1, 2023
    49. Does Mindfulness Improve Intergroup Bias, Internalized Bias, and Anti-Bias Outcomes?: A Meta-Analysis of the Evidence and Agenda for Future Research Personality and Social Psychology Bulletin · June 29, 2023
    50. A pilot evaluation of an 8-week mindfulness-based stress reduction program for people with pre-symptomatic Huntington's disease. Journal of community genetics · July 17, 2023
    51. Mindfulness Combined With Exercise Online (MOVE) Compared With a Self-management Guide for Adults With Chronic Pain: A Feasibility Randomized Controlled Trial. Clinical Journal of Pain · August 1, 2023
    52. Stress and suicidal ideation in Korean baby boomers: the mediating effect of mindfulness and meaning in life. Frontiers in Psychology · August 28, 2023
    53. Impact of a Stress Reduction, Meditation, and Mindfulness Program in Patients with Chronic Heart Failure: A Randomized Controlled Trial. Arquivos brasileiros de cardiologia · October 1, 2023
    54. The Impact of Outdoor in Nature Mindfulness on the Mental Well-being of Children and Adolescents. A Mental Health and Cross-cultural Approach. Materia socio-medica · 2024
    55. Increased wakefulness as measured by the WAKE-16 is related to mindfulness and emotional self-regulation in experienced Buddhist meditators. Progress in Brain Research · 2024
    56. A COMPREHENSIVE REVIEW ON THE CORRELATION BETWEEN BUDDHISM AND PSYCHOLOGY The American Journal of Interdisciplinary Innovations and Research · 2024
    57. Pengaruh intervensi Mindfulness-Based Stress Reduction (MBSR) terhadap kecenderungan baby blues pada ibu postpartum Procedia : Studi Kasus dan Intervensi Psikologi · March 30, 2024
    58. Lessons from Master Hongyi’s Experiences with Impermanence for Death Education Religions · April 25, 2024
    59. Revisiting The Contemplative Life in The Contemporary Era Jurnal Filsafat Indonesia · April 30, 2024
    60. Examining the Occurrence and Clinical Impact of Difficult Experiences that Emerge during a Mindfulness-Based Intervention among Individuals at High-Risk of Suicide. Mindfulness · June 18, 2024
    61. The Effect of a Mindfulness-Based Stress Reduction Program on Depression and Quality of Life in Cancer Patients: A Meta-Analysis Study. Holistic Nursing Practice · October 10, 2024
    62. Quality improvement project aimed at integrating an adapted mindfulness-based stress reduction programme into a paediatric psychology service BMJ Open Quality · October 25, 2024
    63. Defining Mindfulness: A Review of Existing Definitions and Suggested Refinements Mindfulness · 2025
    64. A Pilot Randomized Controlled Trial Testing the Feasibility and Acceptability of Helping Ease Anxiety and Depression after Stroke (HEADS: UP): An Online Mindfulness-Based Intervention for Stroke Survivors Mindfulness · July 1, 2025
    65. Rumination and alexithymia serially mediate the relationship between mindfulness and anxiety symptoms in Chinese university students. Scientific Reports · July 16, 2025
    66. Consciousness, mindfulness, and introspection: integrating first- and second-person phenomenological inquiry with experimental and EEG data to study the mind. Frontiers in Psychology · September 8, 2025
    67. Investigating the long-term impact of a programme of mindfulness combined with exercise delivered online (MOVE) on individuals living with chronic pain-an exploratory one-year follow-up of a feasibility randomised control trial. PLoS One · September 30, 2025
    68. Turkish Version of the Mindfulness in Couple Relationships Scale: Validity, Reliability and Psychometric Properties Journal of Family Therapy · November 1, 2025
  2. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.

    Retracted August 2024 Cited 50 times since Retraction notice (opens in new tab)

    Show the 50 citing papers
    1. Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushrooms Journal of Psychedelic Studies · September 9, 2024
    2. The Psychedelic Renaissance: A Catholic Perspective. Linacre Q · September 15, 2024
    3. Beyond Pharmacology: A Narrative Review of Alternative Therapies for Anxiety Disorders. Diseases · September 16, 2024
    4. Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use Journal of Psychoactive Drugs · September 19, 2024
    5. Mechanisms of psilocybin on the treatment of posttraumatic stress disorder Journal of Psychopharmacology · October 3, 2024
    6. Psychoactive substances for the treatment of neuropsychiatric disorders. Asian Journal of Psychiatry · November 1, 2024
    7. MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations. European Child & Adolescent Psychiatry · November 1, 2024
    8. Religious Social Integration, Psychedelics, and Psychological Distress. Journal of Psychoactive Drugs · November 7, 2024
    9. The historical opposition to psychedelic research and implications for credibility in psychiatry. CNS Spectrums · November 21, 2024
    10. Exploring the regulatory framework of psychedelics in the US & Europe. Asian Journal of Psychiatry · December 1, 2024
    11. MDMA-assisted psychotherapy for the treatment of PTSD: A systematic review and meta-analysis of randomized controlled trials (RCTs). Neuropsychopharmacology Reports · December 1, 2024
    12. Effects of psychedelics on neurogenesis and broader neuroplasticity: a systematic review. Mol Med · December 19, 2024
    13. Is there a place for psychedelics in sports practice? Acta Neuropsychiatrica · 2025
    14. MDMA and MDMA-Assisted Therapy. American Journal of Psychiatry · 2025
    15. Post-traumatic stress disorder in psychedelic research. International review of neurobiology · 2025
    16. Serotonergic psychedelics for depression: A comprehensive overview. International review of neurobiology · 2025
    17. Religion, Psychedelics, Risky Behavior, and Violence. Journal of Psychoactive Drugs · 2025
    18. Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users’ Patterns of Use and Perceived Effects Journal of Psychoactive Drugs · January 29, 2025
    19. Social Worker Attitudes towards Psychedelics Clinical Social Work Journal · February 6, 2025
    20. Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies. Molecular Psychiatry · March 1, 2025
    21. Psychedelic iatrogenic structural dissociation: an exploratory hypothesis on dissociative risks in psychedelic use. Frontiers in Psychology · March 4, 2025
    22. Minorities’ diminished psychedelic returns: Depression, suicide, distress, and serious mental illness Drug Science, Policy and Law · April 1, 2025
    23. Successful treatment of intractable MDMA adverse reactions using acupuncture and traditional Chinese medicine Journal of Psychedelic Studies · April 2, 2025
    24. Race and Gender Differences in the Moderating Relationship of Psychedelics on Stigma and Distress Psychedelic Medicine · April 22, 2025
    25. Traumatic Psychedelic Experiences. Current Topics in Behavioral Neurosciences · April 29, 2025
    26. Minorities' Diminished Psychedelic Returns: Income and Educations Impact on Whites, Blacks, Hispanics, and Asians. Journal of Racial and Ethnic Health Disparities · June 1, 2025
    27. Qualitative Analysis of Views of Psychedelic-Assisted Therapy in Low-Income, Urban, Black Americans. Psychedelic Medicine · June 1, 2025
    28. Phase 1 clinical trial on Orgasmic Meditation (OM): Assessing safety and feasibility as a meditation practice for individuals with PTSD. Contemporary Clinical Trials Communications · June 1, 2025
    29. Bioproduction of 3,4-methylenedioxymethamphetamine and derivatives. Biodesign research · June 1, 2025
    30. Assessing the Attitudes of Dutch Mental Health Care Professionals Toward Psychedelic-Assisted Psychotherapy: A Cross-Sectional Exploratory Study Journal of Psychoactive Drugs · June 23, 2025
    31. Fear as medicine: A mixed-methods analysis of 5-MeO-DMT, mental health, and intergenerational healing Applied Psychology Research · June 26, 2025
    32. MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study. The British Journal of Psychiatry · July 11, 2025
    33. Therapeutic Potential of Psychedelics: Mechanisms, Applications, and Challenges Pharmaceutical Science · August 27, 2025
    34. Changing your mind: neuroplastic mechanisms underlying the therapeutic effect of psychedelics in depression, PTSD, and addiction Progress in Neuro-Psychopharmacology and Biological Psychiatry · October 1, 2025
    35. The medical sociological and social epidemiological psychedelics paradigm (MSSEPP) Drug Science, Policy and Law · November 1, 2025
    36. MDMA-Assisted Psychotherapy for PTSD: A Systematic Review of Randomized Control Trials Journal of Psychoactive Drugs · November 5, 2025
    37. MDMA-assisted therapy for major depressive disorder: A seven-month follow-up proof of principle trial Journal of Psychiatric Research · November 27, 2025
    38. Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine. Therapeutic Advances in Psychopharmacology · December 4, 2025
    39. Towards therapeutic paths with mindfulness meditation–based and psychedelics assisted psychotherapies in PTSD: Randomized controlled trials systematic review and meta-analysis Cortica · December 15, 2025
    40. Evidence in practice: implementing KAT in indigenous health services. Frontiers in Psychiatry · 2026
    41. Psychedelics in the age of reproducibility: Reflections on aura, set and setting and the medicalization of mystical-type experiences. International Journal of Drug Policy · 2026
    42. Psychedelics and Sexual Trauma: Effects on Communication and Emotional Connection. The Journal of Sex Research · January 16, 2026
    43. A Blueprint for Implementing Ketamine-Assisted Psychotherapy in Palliative Care: Design, Process, and Treatment Patterns of a Real-World Clinical Program. Journal of Palliative Medicine · March 1, 2026
    44. Effect of app-based mindfulness on extinction recall - a 7T-fMRI study. Scientific Reports · March 25, 2026
    45. Subjective and neurocognitive profiling of clinical doses of 3,4-methylenedioxymethamphetamine (MDMA) in healthy volunteers: implications for therapeutic use Molecular Psychiatry · April 8, 2026
    46. Suggested Guidelines for Applying a Systemic Lens to Psychedelic-Assisted Psychotherapy. Psychedelic Medicine · June 1, 2026
    47. The Entrepreneurship of Psychedelic Negativity: Psymposia, Trauma, Iatrogenic Harm, and Prohibition 2.0 Contemporary Drug Problems · July 10, 2026
    48. MDMA as an early post-trauma intervention in a translational animal model of PTSD. Progress in Neuro-Psychopharmacology and Biological Psychiatry · July 24, 2026
    49. The occurrence and potential role of mystical experiences in MDMA-assisted therapy for PTSD: A secondary analysis Journal of Psychopharmacology · August 6, 2026
    50. MDMA-Assisted Therapy May Decrease PTSD Symptoms, Dissociation, Depression, and Functional Disability: A Systematic Review and Meta-Analysis Harvard Review of Psychiatry · September 8, 2026
  3. RETRACTED: Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ("Ecstasy")

    Retracted September 2003 Cited 41 times since Retraction notice (opens in new tab)

    Show the 41 citing papers
    1. Hypothalamic-pituitary-adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine ('ecstasy') use history: correlation with dopamine receptor sensitivity. Psychiatry Research · September 30, 2003
    2. Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users Human Psychopharmacology: Clinical and Experimental · October 1, 2003
    3. Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users Neuroreport · October 1, 2003
    4. Concentrations and Ratios of Amphetamine, Methamphetamine, MDA, MDMA, and MDEA Enantiomers Determined in Plasma Samples from Clinical Toxicology and Driving Under the Influence of Drugs Cases by GC-NICI-MS* Journal of Analytical Toxicology · November 1, 2003
    5. Neuroimagen y neurotoxicidad inducida por MDMA (éxtasis) Adicciones · December 15, 2003
    6. Multiple molecular and neuropharmacological effects of MDMA (Ecstasy). Life Sciences · January 2, 2004
    7. Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells. Toxicology and Applied Pharmacology · April 15, 2004
    8. Psychedelic drugs: the ups and downs of ecstasy. Nature · May 1, 2004
    9. The Neuropsychopharmacology and Toxicology of 3,4‐methylenedioxy‐N‐ethyl‐amphetamine (MDEA) CNS Drug Reviews · June 1, 2004
    10. Use of MDA (The "Love Drug") and Methamphetamine in Toronto by Unsuspecting Users of Ecstasy (MDMA) Journal of Forensic Sciences · September 1, 2004
    11. Effect of Repeated (‘Binge’) Dosing of MDMA to Rats Housed at Normal and High Temperature on Neurotoxicdamage to Cerebral 5-Ht and Dopamine Neurones Journal of Psychopharmacology · September 1, 2004
    12. Psychedelics in psychiatry The British Journal of Psychiatry · December 30, 2005
    13. The Renewal of Psychedelic Research: Implications for Humanistic and Transpersonal Psychology. The Humanistic Psychologist · 2006
    14. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects Journal of Psychopharmacology · March 1, 2006
    15. Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues Drug and Alcohol Review · May 1, 2006
    16. Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques. Neuroscience · October 13, 2006
    17. Transcriptomic configuration of mouse brain induced by adolescent exposure to 3,4-methylenedioxymethamphetamine. Toxicology and Applied Pharmacology · May 15, 2009
    18. Identification of post-generation effect of 3,4-methylenedioxymethamphetamine on the mouse brain by large-scale gene expression analysis. Toxicology Letters · February 24, 2010
    19. The A2a adenosine receptor modulates the reinforcement efficacy and neurotoxicity of MDMA Journal of Psychopharmacology · January 24, 2011
    20. A Historical Review of MDMA The Open Forensic Science Journal · May 12, 2011
    21. Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nature reviews. Neuroscience · June 12, 2013
    22. MDMA and the “Ecstasy Paradigm” Journal of Psychoactive Drugs · 2014
    23. The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder. Journal of Psychoactive Drugs · 2015
    24. MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults. Progress in Neuro-Psychopharmacology and Biological Psychiatry · January 4, 2016
    25. The Psychedelic Renaissance: Horizons, the Fifth Annual Conference on Psychedelic Research Einstein Journal of Biology and Medicine · March 2, 2016
    26. MDMA as a Probe and Treatment for Social Behaviors Cell · July 1, 2016
    27. Perceptions of the medicinal value of hallucinogenic drugs among college students Journal of Psychedelic Studies · October 17, 2017
    28. Progress and promise for the MDMA drug development program. Psychopharmacology · November 20, 2017
    29. Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder. Journal of Contemporary Psychotherapy · January 6, 2018
    30. Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine ACS Chemical Neuroscience · July 12, 2018
    31. Chronic administration of amphetamines disturbs development of neural progenitor cells in young adult nonhuman primates. Progress in Neuro-Psychopharmacology and Biological Psychiatry · July 13, 2018
    32. Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine Journal of Neuroscience · November 30, 2020
    33. Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms Pharmacological Reviews · December 16, 2020
    34. MDMA Is Not Ecstasy: The Production of Pharmaceutical Safety through Documents in Clinical Trials. Medical Anthropology Quarterly · March 1, 2021
    35. Debunking the myth of 'Blue Mondays': No evidence of affect drop after taking clinical MDMA. Journal of Psychopharmacology · December 13, 2021
    36. Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review Cureus · June 28, 2022
    37. Disorders due to Substance Use: Hallucinogens and MDMA-Related Substances Tasman’s Psychiatry · 2023
    38. A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder. Focus · July 1, 2023
    39. Preventing the Gaps in Psychedelic Research from Becoming Practice Pitfalls: A Translational Research Agenda. Psychedelic Medicine · December 13, 2023
    40. MDMA and MDMA-Assisted Therapy. American Journal of Psychiatry · 2025
    41. Psychedelics and Reward Processing: Before and After the 1970 Controlled Substances Act Psychedelic Medicine · July 24, 2026
  4. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department.

    Retracted June 2017 Cited 28 times since Retraction notice (opens in new tab)

    Show the 28 citing papers
    1. Classics in Chemical Neuroscience: Ketamine. ACS Chemical Neuroscience · June 21, 2017
    2. Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials. Journal of Affective Disorders · August 15, 2017
    3. The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis American Journal of Psychiatry · October 3, 2017
    4. Low-dose ketamine for treatment resistant depression in an academic clinical practice setting. Journal of Affective Disorders · October 15, 2017
    5. Ketamine's antidepressant effect is mediated by energy metabolism and antioxidant defense system. Scientific Reports · November 17, 2017
    6. Side-effects associated with ketamine use in depression: a systematic review. The Lancet Psychiatry · 2018
    7. Efficacy of different doses of ketamine as a bolus in major depressive disorder. Caspian journal of internal medicine · 2018
    8. Glutamatergic Modulators in Depression Harvard Review of Psychiatry · February 21, 2018
    9. Can we increase the speed and efficacy of antidepressant treatments? Part II. Glutamatergic and RNA interference strategies. European Neuropsychopharmacology · April 2018
    10. Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression Journal of Psychopharmacology · September 27, 2018
    11. Role of copper in depression. Relationship with ketamine treatment. Medical Hypotheses · October 2018
    12. Efficacy and Safety of a Rapid Intravenous Injection of Ketamine 0.5 mg/kg in Treatment-Resistant Major Depression: An Open 4-Week Longitudinal Study. Journal of Clinical Psychopharmacology · December 2018
    13. An update on ketamine and its two enantiomers as rapid-acting antidepressants Expert Review of Neurotherapeutics · December 4, 2018
    14. Efficacy of ketamine therapy in the treatment of depression Indian Journal of Psychiatry · 2019
    15. Potential Anti-Depressive Treatment Maneuvers from Bench to Bedside Depressive Disorders: Mechanisms, Measurement and Management · 2019
    16. The olfactory bulb is a source of high-frequency oscillations (130-180 Hz) associated with a subanesthetic dose of ketamine in rodents. Neuropsychopharmacology · January 2019
    17. Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine. Pharmacology, Biochemistry, and Behavior · June 1, 2019
    18. Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective Psychiatry and Clinical Neurosciences · June 19, 2019
    19. Ketamine and depression: a narrative review Drug Design, Development and Therapy · August 1, 2019
    20. The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial Frontiers in Pharmacology · November 19, 2019
    21. Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression Brain Sciences · December 11, 2020
    22. Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review Journal of Psychopharmacology · June 26, 2021
    23. Ketamine for Treatment-Resistant Depression Mustansiriya Medical Journal · July 1, 2021
    24. A unique case of very low‐dose subcutaneous ketamine use: Maintenance option of ketamine for treatment‐resistant depression Clinical Case Reports · December 1, 2022
    25. Oral ketamine for depression: An updated systematic review The World Journal of Biological Psychiatry · January 18, 2023
    26. Ketamine and the Disinhibition Hypothesis: Neurotrophic Factor-Mediated Treatment of Depression. Pharmaceuticals · May 12, 2023
    27. The effects of ketamine and esketamine on functional outcomes in major depressive disorder and treatment-resistant depression: A systematic review Journal of Psychiatric Research · October 30, 2025
    28. Open-label Prospective, Interventional Study Assessing Efficacy and Safety of Intramuscular Ketamine for Suicidal Ideation in a Tertiary Care Hospital. Indian Journal of Psychological Medicine · November 13, 2025
  5. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.

    Retracted August 2024 Cited 28 times since Retraction notice (opens in new tab)

    Show the 28 citing papers
    1. Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushrooms Journal of Psychedelic Studies · September 9, 2024
    2. Novel Benzofuran Derivatives Induce Monoamine Release and Substitute for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine. Journal of Pharmacology and Experimental Therapeutics · September 18, 2024
    3. MDMA for treatment of PTSD and neurorehabilitation in military populations Neurorehabilitation · September 27, 2024
    4. Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine—A Systematic Review and Meta-Analysis Psychoactives · October 4, 2024
    5. MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations. European Child & Adolescent Psychiatry · November 1, 2024
    6. Novel Pharmacologic and Other Somatic Treatment Approaches for Posttraumatic Stress Disorder in Adults: State of the Evidence. American Journal of Psychiatry · December 1, 2024
    7. The Role of Music in Psychedelic-Assisted Therapy: A Comparative Analysis of Neuroscientific Research, Indigenous Entheogenic Ritual, and Contemporary Care Models. Psychedelic Medicine · December 2, 2024
    8. Informed Consent in Psychedelic-Assisted Therapy. Current Topics in Behavioral Neurosciences · December 31, 2024
    9. Is there a place for psychedelics in sports practice? Acta Neuropsychiatrica · 2025
    10. MDMA and MDMA-Assisted Therapy. American Journal of Psychiatry · 2025
    11. Post-traumatic stress disorder in psychedelic research. International review of neurobiology · 2025
    12. Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor Journal of Child and Adolescent Psychopharmacology · January 6, 2025
    13. Cardiovascular effects and safety of classic psychedelics. Nature cardiovascular research · February 1, 2025
    14. Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies. Molecular Psychiatry · March 1, 2025
    15. Safety and efficacy of methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in post-traumatic stress disorder: An overview of systematic reviews and meta-analyses. Australian & New Zealand Journal of Psychiatry · April 1, 2025
    16. Successful treatment of intractable MDMA adverse reactions using acupuncture and traditional Chinese medicine Journal of Psychedelic Studies · April 2, 2025
    17. Advances in the management of posttraumatic stress disorder after critical illness: a narrative review Emergency and Critical Care Medicine · April 7, 2025
    18. Neurochemical, Neurocircuitry, and Psychopathological Mechanisms of PTSD: Emerging Pharmacotherapies and Clinical Perspectives. ACS Chemical Neuroscience · June 10, 2025
    19. Authenticity and Love Drugs: Insights from Psychedelic Therapy. AJOB Neuroscience · June 16, 2025
    20. Therapeutic Potential of Psychedelics: Mechanisms, Applications, and Challenges Pharmaceutical Science · August 27, 2025
    21. The medical sociological and social epidemiological psychedelics paradigm (MSSEPP) Drug Science, Policy and Law · November 1, 2025
    22. MDMA-Assisted Psychotherapy for PTSD: A Systematic Review of Randomized Control Trials Journal of Psychoactive Drugs · November 5, 2025
    23. MDMA-assisted therapy for major depressive disorder: A seven-month follow-up proof of principle trial Journal of Psychiatric Research · November 27, 2025
    24. Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine. Therapeutic Advances in Psychopharmacology · December 4, 2025
    25. A neurocognitive account of complex PTSD: self-modelling, affective dysregulation, and implications for MDMA-assisted and targeted psychotherapies. European Journal of Psychotraumatology · March 19, 2026
    26. Subjective and neurocognitive profiling of clinical doses of 3,4-methylenedioxymethamphetamine (MDMA) in healthy volunteers: implications for therapeutic use Molecular Psychiatry · April 8, 2026
    27. The occurrence and potential role of mystical experiences in MDMA-assisted therapy for PTSD: A secondary analysis Journal of Psychopharmacology · August 6, 2026
    28. MDMA-Assisted Therapy May Decrease PTSD Symptoms, Dissociation, Depression, and Functional Disability: A Systematic Review and Meta-Analysis Harvard Review of Psychiatry · September 8, 2026
  6. RETRACTED ARTICLE: A mechanistic model of the neural entropy increase elicited by psychedelic drugs

    Retracted September 2022 Cited 13 times since Retraction notice (opens in new tab)

    Show the 13 citing papers
    1. Ritualistic use of ayahuasca enhances a shared functional connectome identity with others bioRxiv (Cold Spring Harbor Laboratory) · October 11, 2022
    2. Self-transcendent experiences as promoters of ecological wellbeing? Exploration of the evidence and hypotheses to be tested Frontiers in Psychology · November 14, 2022
    3. Pattern breaking: a complex systems approach to psychedelic medicine Neuroscience of Consciousness · 2023
    4. A complex systems perspective on psychedelic brain action. Trends in Cognitive Sciences · February 3, 2023
    5. Reconsidering Context in Psychedelic Research: Rituals as Ancient Libraries of Knowledge Journal of Scientific Exploration · February 11, 2023
    6. Reduced emergent character of neural dynamics in patients with a disrupted connectome Neuroimage · February 11, 2023
    7. Lysergic Acid Diethylamide Alters the Effects of Brain Stimulation in Rodents. Psychedelic Medicine · March 1, 2023
    8. A whole-brain model of the neural entropy increase elicited by psychedelic drugs. Scientific Reports · April 17, 2023
    9. High-density exploration of activity states in a multi-area brain model bioRxiv (Cold Spring Harbor Laboratory) · May 18, 2023
    10. When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research Neuroethics · November 6, 2023
    11. A role for the serotonin 2A receptor in the expansion and functioning of human transmodal cortex. Brain · 2024
    12. Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression Nature Mental Health · August 5, 2024
    13. Psychological Effects Related to Psychedelic Substance Use in the Previous 12 Months European Journal of Psychology Open · May 28, 2025
  7. The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis.

    Retracted May 2025 Cited 9 times since Retraction notice (opens in new tab)

    Show the 9 citing papers
    1. Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework Therapeutic Advances in Psychopharmacology · June 8, 2025
    2. From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs. Expert Review of Clinical Pharmacology · June 11, 2025
    3. Above the threshold, beyond the trip: the role of the 5-HT2A receptor in psychedelic-induced neuroplasticity and antidepressant effects Molecular Psychiatry · August 23, 2025
    4. Religious and spiritual experiences from a neuroscientific and complex systems perspective. Neuroscience & Biobehavioral Reviews · October 1, 2025
    5. Cyberdelics: Virtual reality hallucinations modulate cognitive-affective processes. Dialogues in Clinical Neuroscience · December 1, 2025
    6. Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety General Hospital Psychiatry · December 9, 2025
    7. MDMA and psilocybin regulate oligodendrocyte-lineage cell numbers and anxiety-like behaviors in a rat model of fear. Biological Psychiatry · February 3, 2026
    8. Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil. Journal of Psychoactive Drugs · March 20, 2026
    9. Where is the sweet spot for psychedelic-enhanced fear extinction? An integrative quantitative synthesis of dose-effect patterns in rodent models. Journal of Psychopharmacology · August 3, 2026
  8. Efficacy of Ketamine in Bipolar Depression: Systematic Review and Meta-analysis.

    Retracted July 2018 Cited 6 times since Retraction notice (opens in new tab)

    Show the 6 citing papers
    1. Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development Frontiers in Pharmacology · July 5, 2018
    2. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression. Journal of Psychiatric Research · November 2018
    3. Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: A meta-analysis of randomized controlled trials. Journal of Affective Disorders · May 1, 2019
    4. Effects of ketamine in electroconvulsive therapy for major depressive disorder: meta-analysis of randomised controlled trials General Psychiatry · June 18, 2020
    5. Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis Frontiers in Psychiatry · February 1, 2024
    6. Experiences of Awe Mediate Ketamine's Antidepressant Effects: Findings From a Randomized Controlled Trial in Treatment-Resistant Depression. Biological Psychiatry Global Open Science · July 1, 2024
  9. Effects of Sahaj Samadhi meditation on heart rate variability and depressive symptoms in patients with late-life depression.

    Retracted May 2021 Cited 5 times since Retraction notice (opens in new tab)

    Show the 5 citing papers
    1. Video-delivered emotion-focused mindfulness therapy for late- life anxiety: study protocol for a feasibility randomized controlled trial. Pilot and Feasibility Studies · September 3, 2021
    2. Blunted superior temporal gyrus activity to negative emotional expression after mindfulness-based cognitive therapy for late-life depression. Frontiers in Aging Neuroscience · 2022
    3. Systematic Review for the Medical Applications of Meditation in Randomized Controlled Trials. International Journal of Environmental Research and Public Health · January 22, 2022
    4. Effectiveness of Mantra-Based Meditation on Mental Health: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health · March 13, 2022
    5. The effectiveness of mindfulness-based meditation treatments for late life anxiety: a systematic review of randomized controlled trials Aging & Mental Health · July 31, 2022
  10. Delusion, possession and religion†.

    Retracted May 2021 Cited 5 times since Retraction notice (opens in new tab)

    Show the 5 citing papers
    1. [Evolution of views on the phenomenon of spiritual possession within the framework of psychiatric pathology (psychopathological, transnosological and transcultural aspects)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2024
    2. “The Demons Made Me Do It” The Journal of Nervous and Mental Disease · 2024
    3. Magical Thinking and Mystical Experience: An Exploration of Delusional Disorder in Schizophrenic Patients. Iranian Journal of Nursing and Midwifery Research · September 11, 2025
    4. Jinn-possession with psychosis, childhood traumatic experiences, and dissociation; a comparison with schizophrenia in the Southeastern region of Türkiye. BMC Psychology · September 26, 2025
    5. Divine shadows and broken minds: cultural and magico-religious beliefs in schizophrenia Mental Health, Religion & Culture · September 21, 2026
  11. Mindfulness-based randomized controlled trials led to brain structural changes: an anatomical likelihood meta-analysis.

    Retracted July 2025 Cited 5 times since Retraction notice (opens in new tab)

    Show the 5 citing papers
    1. Both online and face-to-face mindfulness meditation can change cortical structure in internet gaming disorder. Journal of Psychiatric Research · October 1, 2025
    2. Investigator Meditation Practice Predicts Efficacy of Child/Adolescent Mindfulness-Based Interventions: A Meta-Analysis. Psychotherapy and Psychosomatics · October 7, 2025
    3. Good vibrations: Sternal vibration enhances white matter density and interoceptive awareness. Research Square · December 22, 2025
    4. Efficacy of mindfulness-based cognitive therapy in mitigating depressive symptoms and suicidal ideation among institutionalized patients with major depressive disorder: findings from a randomized controlled trial. European Archives of Psychiatry and Clinical Neuroscience · June 12, 2026
    5. A randomized controlled trial comparing Mindfulness and Heartfulness meditation programmes on stress, anxiety, depressive symptoms and wellbeing among distance-learning postgraduates Frontiers in Psychology · September 17, 2026
  12. Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial.

    Retracted January 2026 Cited 5 times since Retraction notice (opens in new tab)

    Show the 5 citing papers
    1. Symptom trajectories and clinical outcomes of intravenous ketamine in treatment-resistant depression: A real-world study using group-based trajectory modeling. Journal of Affective Disorders · January 23, 2026
    2. The use of repetitive transcranial magnetic stimulation (rTMS), electroconvulsive therapy (ECT), ketamine, and esketamine in reducing suicidality in major depressive disorder: A comprehensive narrative review Psychiatry Research · February 19, 2026
    3. Blinding Integrity in Psychedelic Randomized Clinical Trials JAMA Psychiatry · April 15, 2026
    4. A systematic review of ketamine and esketamine-induced long-term potentiation and synaptic scaling: Do the molecular and synaptic plasticity effects inform dosing intervals? Journal of Affective Disorders · April 15, 2026
    5. Multimodal predictors of response to intravenous ketamine in treatment-resistant depression: toward personalized treatment in major depressive and bipolar disorders. CNS Spectrums · September 28, 2026
  13. Effects of "Mindfulness Acceptance Insight Commitment" Training on Flow State and Mental Health of College Swimmers: A Randomized Controlled Experimental Study.

    Retracted January 2024 Cited 4 times since Retraction notice (opens in new tab)

    Show the 4 citing papers
    1. The Impact of Yoga on Athletes' Mental Well-Being: An Experimental Study. Cureus · August 1, 2024
    2. The relationship between China university basketball association athletes' mindfulness, self-efficacy in sports training, and training competition satisfaction: a cross-sectional and longitudinal study. BMC Psychology · February 2, 2026
    3. Mindfulness en deportistas de resistencia: beneficios para el bienestar psicológico y el rendimiento deportivo – Una revisión sistemática Cuadernos de Psicologia del Deporte · April 22, 2026
    4. Mindfulness-based interventions for competitive anxiety in athletes: the moderating role of control type-Preliminary evidence from a systematic review and meta-analysis. Frontiers in Psychology · May 28, 2026
  14. Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.

    Retracted August 2024 Cited 3 times since Retraction notice (opens in new tab)

    Show the 3 citing papers
    1. Neuroimaging and the Investigation of Drug-Drug Interactions Involving Psychedelics. Neuroscience Insights · October 8, 2024
    2. Psychedelic Therapist Sexual Misconduct and Other Adverse Experiences Among a Sample of Naturalistic Psychedelic Users. Psychedelic Medicine · March 1, 2025
    3. MDMA-Assisted Therapy May Decrease PTSD Symptoms, Dissociation, Depression, and Functional Disability: A Systematic Review and Meta-Analysis Harvard Review of Psychiatry · September 8, 2026
  15. RETRACTED ARTICLE: Social media usage and students’ social anxiety, loneliness and well-being: does digital mindfulness-based intervention effectively work?

    Retracted May 2025 Cited 3 times since Retraction notice (opens in new tab)

    Show the 3 citing papers
    1. Mindfulness-Based Intervention in Schools: Addressing Social Media Burnout and Enhancing Well-Being in Adolescents. Children (Basel, Switzerland) · June 23, 2025
    2. Autonomic and psychophysiological effects of a 13-week mindfulness-based intervention in university students Frontiers in Psychology · February 4, 2026
    3. Scale development and validation of social media mindfulness: evidence from Chinese Douyin users Frontiers in Psychology · June 12, 2026
  16. Intervention of Fluency and Anxiety in Mindfulness Training of Shooting.

    Retracted October 2023 Cited 2 times since Retraction notice (opens in new tab)

    Show the 2 citing papers
    1. Effects of mindfulness intervention on competition state anxiety in sprinters—a randomized controlled trial Frontiers in Psychology · October 31, 2024
    2. Mindfulness and traditional training: A 16 – week study on their combined effect on shooting accuracy and anxiety in football players Health sport rehabilitation · December 21, 2025
  17. In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice.

    Retracted December 2023 Cited 2 times since Retraction notice (opens in new tab)

    Show the 2 citing papers
    1. The Potential Neuroinflammatory Attenuation Effects of Thymoquinone against 3, 4-Methylenedioxymethamphetamine-Induced Microglial Activation in BV2 Mouse Cell Line bioRxiv Preprint Server · June 16, 2025
    2. The effects of acute and repeated adolescent MDMA exposure on behavior, cognition, and the monoamine neurotransmitter systems: A review of human and pre-clinical research Behavioural Brain Research · February 10, 2026
  18. The evolution of ancient healing practices: From shamanism to Hippocratic medicine: A review.

    Retracted January 2026 Cited 2 times since Retraction notice (opens in new tab)

    Show the 2 citing papers
    1. PERFORMATIVE ARCHIVES: EMBODYING MEMORY, ENVIRONMENT, AND SPIRIT IN INDIA’S INDIGENOUS KNOWLEDGE SYSTEMS ShodhKosh: Journal of Visual and Performing Arts · March 27, 2026
    2. Perspectives on Meditation-based Preparation for Psychedelic Experiences: Insights from Practitioners with Combined Meditation and Psychedelic Experience Mindfulness · August 15, 2026
  19. Mnemonic Discrimination Deficits in First Episode Psychosis and a Ketamine Model Suggests Dentate Gyrus Pathology Linked to NMDA-Receptor Hypofunction

    Retracted March 2018 Cited 1 time since Retraction notice (opens in new tab)

    Show the citing paper
    1. Δ9-Tetrahydrocannabinol During Encoding Impairs Perceptual Details yet Spares Context Effects on Episodic Memory. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · 2020
  20. A training programme involving automatic self-transcending meditation in late-life depression: preliminary analysis of an ongoing randomised controlled trial

    Retracted May 2021 Cited 1 time since Retraction notice (opens in new tab)

    Show the citing paper
    1. Effectiveness of Mantra-Based Meditation on Mental Health: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health · March 13, 2022
  21. RETRACTED ARTICLE: A Review on Meditation: History, Transcendental Dimensions and Application in Psychology and Psychotherapy

    Retracted November 2025 Cited 1 time since Retraction notice (opens in new tab)

    Show the citing paper
    1. Transcendental communication and cultural sustainability: rethinking spiritual responsibility at the Bali Spirit Festival Journal of Tourism and Cultural Change · August 31, 2026
  22. Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study.

    Retracted March 2026 Cited 1 time since Retraction notice (opens in new tab)

    Show the citing paper
    1. Pharmacological modulation of anxiety-like behavior by flumazenil, midazolam, and ketamine in rats: Evidence from aversive ultrasonic vocalizations and elevated plus maze. Pharmacology, Biochemistry, and Behavior · May 25, 2026

Retracted 28

The journal has withdrawn the paper; its findings should not be relied on.

  1. The influence mechanism of mindfulness training on college students' psychological stress regulation: a mediation model with moderating effect.

    Frontiers in Public Health · February 26, 2026 Retraction notice (opens in new tab)

  2. Universal consciousness as foundational field: A theoretical bridge between quantum physics and non-dual philosophy

    AIP Advances · November 1, 2025 Retraction notice (opens in new tab)

  3. RETRACTED ARTICLE: A Review on Meditation: History, Transcendental Dimensions and Application in Psychology and Psychotherapy

    Journal of Contemporary Psychotherapy · February 6, 2025 Retraction notice (opens in new tab)

  4. Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study.

    The British Journal of Psychiatry · January 7, 2025 Retraction notice (opens in new tab)

  5. Correlation analysis between clinical effective emotional treatment and plasma N-methyl-D-aspartate receptor function-related indexes.

    Frontiers in Neuroscience · 2025 Retraction notice (opens in new tab)

  6. The evolution of ancient healing practices: From shamanism to Hippocratic medicine: A review.

    Medicine · July 1, 2024 Retraction notice (opens in new tab)

  7. Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial.

    BMC Psychiatry · May 7, 2024 Retraction notice (opens in new tab)

  8. The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis.

    Journal of Psychopharmacology · May 1, 2024 Retraction notice (opens in new tab)

  9. RETRACTED ARTICLE: Social media usage and students’ social anxiety, loneliness and well-being: does digital mindfulness-based intervention effectively work?

    BMC Psychology · October 31, 2023 Retraction notice (opens in new tab)

  10. Mindfulness-based randomized controlled trials led to brain structural changes: an anatomical likelihood meta-analysis.

    Scientific Reports · October 27, 2023 Retraction notice (opens in new tab)

  11. Acute psilocybin increased cortical activities in rats

    Frontiers in Neuroscience · May 23, 2023 Retraction notice (opens in new tab)

  12. Intervention of Fluency and Anxiety in Mindfulness Training of Shooting.

    Scanning · 2022 Retraction notice (opens in new tab)

  13. Effects of "Mindfulness Acceptance Insight Commitment" Training on Flow State and Mental Health of College Swimmers: A Randomized Controlled Experimental Study.

    Frontiers in Psychology · 2022 Retraction notice (opens in new tab)

  14. In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice.

    Neurotoxicology · March 2021 Retraction notice (opens in new tab)

  15. Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.

    Psychopharmacology · November 21, 2020 Retraction notice (opens in new tab)

  16. RETRACTED ARTICLE: A mechanistic model of the neural entropy increase elicited by psychedelic drugs

    Scientific Reports · October 20, 2020 Retraction notice (opens in new tab)

  17. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.

    Psychopharmacology · August 1, 2020 Retraction notice (opens in new tab)

  18. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.

    Psychopharmacology · September 1, 2019 Retraction notice (opens in new tab)

  19. Effects of Sahaj Samadhi meditation on heart rate variability and depressive symptoms in patients with late-life depression.

    The British Journal of Psychiatry · November 28, 2018 Retraction notice (opens in new tab)

  20. RETRACTED: Long-term systemic treatment with lysergic acid diethylamide causes retinal damage in CD1 mice

    Human & Experimental Toxicology · November 25, 2018 Retraction notice (opens in new tab)

  21. Delusion, possession and religion†.

    Nordic Journal of Psychiatry · September 1, 2018 Retraction notice (opens in new tab)

  22. Mnemonic Discrimination Deficits in First Episode Psychosis and a Ketamine Model Suggests Dentate Gyrus Pathology Linked to NMDA-Receptor Hypofunction

    Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · February 28, 2017 Retraction notice (opens in new tab)

  23. A training programme involving automatic self-transcending meditation in late-life depression: preliminary analysis of an ongoing randomised controlled trial

    BJPsych Open · March 1, 2016 Retraction notice (opens in new tab)

  24. Efficacy of Ketamine in Bipolar Depression: Systematic Review and Meta-analysis.

    Journal of Psychiatric Practice · November 1, 2015 Retraction notice (opens in new tab)

  25. Standardised Mindfulness-Based Interventions in Healthcare: An Overview of Systematic Reviews and Meta-Analyses of RCTs

    PLoS One · April 16, 2015 Retraction notice (opens in new tab)

  26. Dreaming of you: client and therapist dreams about each other during psychodynamic psychotherapy.

    Psychotherapy Research · 2014 Retraction notice (opens in new tab)

  27. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department.

    The International Journal of Neuropsychopharmacology · May 5, 2011 Retraction notice (opens in new tab)

  28. RETRACTED: Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ("Ecstasy")

    Science · September 27, 2002 Retraction notice (opens in new tab)

Expressions of concern 2

The journal has flagged unresolved doubts while an investigation is open.

  1. Sleep Quality Improvements After MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder.

    Journal of Traumatic Stress · August 1, 2021 Notice of concern (opens in new tab)

  2. Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder

    Journal of Traumatic Stress · February 19, 2020 Notice of concern (opens in new tab)

Corrected 452

The journal published a correction; the paper stands with the noted change.

  1. Social emotional learning and autonomic regulation enhance social connectedness in female adolescents with extensive exposure to adverse childhood experiences.

    Journal of Research on Adolescence · September 2026 Correction notice (opens in new tab)

  2. The Neuroscience of Religious and Spiritual Practices: A Systematic Review of Neurotheological Evidence

    Brain and Behavior · August 30, 2026 Correction notice (opens in new tab)

  3. Sleep and psychosis: An integrative review of conceptual and neurophysiological associations.

    Progress in Neuro-Psychopharmacology and Biological Psychiatry · August 14, 2026 Correction notice (opens in new tab)

  4. Exploring Hmong Shamans' Beliefs on Cancer.

    Psycho-Oncology · August 2026 Correction notice (opens in new tab)

  5. Implications of illusionism in consciousness studies: the case of feeling pain in human and non-human animals

    Philosophical Psychology · July 30, 2026 Correction notice (opens in new tab)

  6. Plasticity and language in the anaesthetized human hippocampus.

    Nature · June 1, 2026 Correction notice (opens in new tab)

  7. From Practice to Policy: Promise and Constraints of Contemplative Ethics Interventions in Science.

    Mindfulness · May 19, 2026 Correction notice (opens in new tab)

  8. Effects of Online Versus In-Person Mindfulness-Based Stress Reduction (MBSR): The Impact of Adding Brief Individual Interviews

    Mindfulness · May 12, 2026 Correction notice (opens in new tab)

  9. Cannabis Use and Clinical Outcomes in First Episode Psychosis: Results From a 2‐Year Follow‐Up Study

    Early Intervention in Psychiatry · May 1, 2026 Correction notice (opens in new tab)

  10. The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice.

    Molecular Psychiatry · May 1, 2026 Correction notice (opens in new tab)

  11. Investigating the Effect of the 6-Week Mindful Self-Compassion Program for Emerging Adults (EYL) on Stress Response, Brain Activity, and Self-Compassion Among Chinese University Students: An Electroencephalogram (EEG) Quasi-experimental Study Using Portable EEG Headband.

    Applied Psychophysiology and Biofeedback · April 21, 2026 Correction notice (opens in new tab)

  12. Generative phenomenology and sedimentations

    Continental Philosophy Review · April 20, 2026 Correction notice (opens in new tab)

  13. Acute requirement for the hippocampus in putatively conscious vision revealed by a mouse model of blindsight.

    Current Biology · April 20, 2026 Correction notice (opens in new tab)

  14. “God of Holy Dreaming”: A Retrospective Appreciation of an Aboriginal Prayer and Spirituality in A Prayer Book for Australia

    Journal of Anglican Studies · March 31, 2026 Correction notice (opens in new tab)

  15. Phenomenology and Interpretations of Sleep Paralysis with an Aotearoa New Zealand Sample: Cultural Nuances and Clinical Implications

    Kōtuitui New Zealand Journal of Social Sciences Online · March 29, 2026 Correction notice (opens in new tab)

  16. Neuroimaging insights from Wistar-Kyoto rats under chronic mild stress: morphological and metabolic brain correlates of treatment-resistant depression.

    Scientific Reports · March 27, 2026 Correction notice (opens in new tab)

  17. Big-Five personality traits and dream experiences: A systematic review and meta-analysis.

    Dreaming · March 26, 2026 Correction notice (opens in new tab)

  18. Dream content and slow waves benefit prey against predator in a video game confrontation

    Scientific Reports · March 13, 2026 Correction notice (opens in new tab)

  19. Cogumelos do gênero Psilocybe nas Américas e no Brasil

    Anthropology of Consciousness · March 1, 2026 Correction notice (opens in new tab)

  20. Death reflection and meaning in life: Mediation by self-transcendence and authentic-self pursuit.

    Death Studies · February 28, 2026 Correction notice (opens in new tab)

  21. Which Came First? Utility of Preclinical Models in Cracking the Chicken-or-Egg Relationship between Cannabis Use and Schizophrenia

    Current Addiction Reports · February 27, 2026 Correction notice (opens in new tab)

  22. Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial

    BJPsych Open · February 16, 2026 Correction notice (opens in new tab)

  23. Autonomic and psychophysiological effects of a 13-week mindfulness-based intervention in university students

    Frontiers in Psychology · February 4, 2026 Correction notice (opens in new tab)

  24. Delusion as embodied emotion: a qualitatively driven, multimethod study of first-episode psychosis in the UK.

    The Lancet Psychiatry · February 1, 2026 Correction notice (opens in new tab)

  25. End of life distress as an economic issue: The case for psychedelic-assisted therapy.

    Palliative & Supportive Care · January 28, 2026 Correction notice (opens in new tab)

  26. Psychedelics elicit their effects by 5-HT2A receptor-mediated Gi signalling.

    Nature · January 28, 2026 Correction notice (opens in new tab)

  27. A narrative review on the neurobiology of lucid dreaming: mechanisms and therapeutic potential.

    Annals of Medicine and Surgery · January 21, 2026 Correction notice (opens in new tab)

  28. Psychedelic therapeutics in psychiatric conditions

    Neuropsychopharmacology · January 16, 2026 Correction notice (opens in new tab)

  29. Ibogaine for the treatment of Parkinson's disease: A case report

    Journal of Psychedelic Studies · January 6, 2026 Correction notice (opens in new tab)

  30. Action without agent, but with awareness? meditation and the modulation of agency induced sensory suppression.

    Consciousness and Cognition · 2026 Correction notice (opens in new tab)

  31. Psychological support can be distinguished from psychotherapy: Clarifications for future empirical work.

    General Hospital Psychiatry · 2026 Correction notice (opens in new tab)

  32. Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study.

    Therapeutic Advances in Psychopharmacology · 2026 Correction notice (opens in new tab)

  33. Investigating the effectiveness of structured mindfulness sessions in mitigating burnout among final-year dental students: A mixed-methods analysis.

    PLoS One · 2026 Correction notice (opens in new tab)

  34. A real-world pharmacovigilance study of adverse events associated with esketamine: disproportionality analysis and detection of potential drug-drug interaction signals

    European Journal of Clinical Pharmacology · December 22, 2025 Correction notice (opens in new tab)

  35. Inducing selflessness through a numadelic virtual reality experience: a preliminary study

    Virtual Reality · December 21, 2025 Correction notice (opens in new tab)

  36. Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscape

    Australian & New Zealand Journal of Psychiatry · December 17, 2025 Correction notice (opens in new tab)

  37. ATP-binding cassette transporter polymorphisms and the pharmacokinetics of oral esketamine

    Pharmacogenomics · December 12, 2025 Correction notice (opens in new tab)

  38. Exploring practitioners' perceptions of health behavior changes associated with psychedelic experiences.

    Scientific Reports · November 25, 2025 Correction notice (opens in new tab)

  39. Transcranial Focused Ultrasound for Identifying the Neural Substrate of Conscious Perception.

    Neuroscience & Biobehavioral Reviews · November 19, 2025 Correction notice (opens in new tab)

  40. Feasibility of conducting a pilot randomized trial of a mindfulness-based intervention among sheltered young adults experiencing homelessness.

    Frontiers in Psychology · November 11, 2025 Correction notice (opens in new tab)

  41. Enhancing Mindfulness Effects on Well-Being Using Immersive Virtual Reality in Non-Clinical Populations: Where Are We Going?

    Mindfulness · November 10, 2025 Correction notice (opens in new tab)

  42. A meta-analysis of the effects of mindfulness meditation training on self-reported interoception

    Scientific Reports · November 6, 2025 Correction notice (opens in new tab)

  43. Neural and molecular changes during a mind-body reconceptualization, meditation, and open label placebo healing intervention

    Communications Biology · November 6, 2025 Correction notice (opens in new tab)

  44. Yoga Nidra and Pain: A between-, within-Group Meta-Analysis and Dose Response Meta-Regression

    Complementary Medicine Research · November 4, 2025 Correction notice (opens in new tab)

  45. Knocking at the Doors of Perception: Relating LSD Effects on Low‐Frequency Fluctuations and Regional Homogeneity to Receptor Densities in fMRI

    European Journal of Neuroscience · November 1, 2025 Correction notice (opens in new tab)

  46. The evolution of meaning and the rise of religion and ideology

    Discover Psychology · October 14, 2025 Correction notice (opens in new tab)

  47. Measuring mindfulness in children: breath counting is unrelated to self-reported mindfulness but improves after mindfulness practice in 9–13 year-olds

    Frontiers in Psychology · September 30, 2025 Correction notice (opens in new tab)

  48. The effect of mindfulness group counseling on the anxiety of pregnant women exposed to domestic violence: a randomized clinical trial.

    BMC Psychology · September 29, 2025 Correction notice (opens in new tab)

  49. EEG Connectivity is an Objective Signature of Reduced Consciousness and Sleep Depth

    Brain Topography · September 5, 2025 Correction notice (opens in new tab)

  50. The Mindful Scientist: How Meditation Could Support Ethical Scientific Practice

    Mindfulness · September 2, 2025 Correction notice (opens in new tab)

  51. Psychedelic-assisted therapy as a complex intervention: implications for clinical trial design

    Therapeutic Advances in Psychopharmacology · September 1, 2025 Correction notice (opens in new tab)

  52. Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin

    Molecular Psychiatry · August 26, 2025 Correction notice (opens in new tab)

  53. Appetite measures as correlates of clinical response in mood disorders treated with ketamine: systematic review

    Frontiers in Nutrition · August 21, 2025 Correction notice (opens in new tab)

  54. Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder

    Neuropharmacology · August 21, 2025 Correction notice (opens in new tab)

  55. How an Onaya Dreams: A Healer's Affinal Relationship With Plants

    Anthropology of Consciousness · August 11, 2025 Correction notice (opens in new tab)

  56. Therapeutic and legal aspects of psilocybin in cancer-related depression

    Frontiers in Psychiatry · August 4, 2025 Correction notice (opens in new tab)

  57. One Word, Many Faces: The Italian Validation of the Multiscale Dissociation Inventory

    Journal of Trauma & Dissociation · August 2, 2025 Correction notice (opens in new tab)

  58. The Impact of Understanding and Openness on State Mindfulness Following a Brief Meditation: A Sham Controlled Study

    Mindfulness · August 1, 2025 Correction notice (opens in new tab)

  59. Ketamine-Assisted Recovery (KARE): protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risks

    BMJ Open · August 1, 2025 Correction notice (opens in new tab)

  60. Health-related behavioral changes following the use of psychedelics in naturalistic settings.

    Preventive Medicine Reports · August 1, 2025 Correction notice (opens in new tab)

  61. MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study.

    The British Journal of Psychiatry · July 11, 2025 Correction notice (opens in new tab)

  62. Inhibition of oxidative stress, neuroinflammatory cytokines, and protein expressions contributes to the antipsychotic effects of geraniol in mice with ketamine-induced schizophrenia.

    Journal of Neuroimmune Pharmacology · July 3, 2025 Correction notice (opens in new tab)

  63. Choroid plexus apocrine secretion shapes CSF proteome during mouse brain development.

    Nature Neuroscience · July 1, 2025 Correction notice (opens in new tab)

  64. Can ketamine therapy overcome treatment-resistant depression in Alzheimer's disease and older adults? Preclinical and clinical evidence.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · July 1, 2025 Correction notice (opens in new tab)

  65. Impact of Low-Dose Ketamine Infusion on Intracranial Pressure and Hemodynamics in Septic Shock Patients.

    Neurocritical care · June 18, 2025 Correction notice (opens in new tab)

  66. Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trial.

    European Neuropsychopharmacology · June 17, 2025 Correction notice (opens in new tab)

  67. Psilocybin’s acute and persistent brain effects: a precision imaging drug trial

    Scientific Data · June 5, 2025 Correction notice (opens in new tab)

  68. Brief Interactive Virtual Reality Mindfulness Training with Real-Time Biofeedback for Anxiety Reduction: A Pilot Study.

    Applied Psychophysiology and Biofeedback · June 4, 2025 Correction notice (opens in new tab)

  69. A neuroscientific model of near-death experiences.

    Nature Reviews Neurology · June 1, 2025 Correction notice (opens in new tab)

  70. Psilocybin's lasting action requires pyramidal cell types and 5-HT2A receptors.

    Nature · June 1, 2025 Correction notice (opens in new tab)

  71. Integrating the Mindfulness-Acceptance-Commitment framework with Self-Determination Theory principles to promote Need-Supportive Sport Coaching.

    Psychology of Sport And Exercise · May 31, 2025 Correction notice (opens in new tab)

  72. A New Way of “Thinking” Consciousness: Nietzsche, Wittgenstein, and Neo-Materialism

    Religions · May 12, 2025 Correction notice (opens in new tab)

  73. The Efficacy and Durability of Mindfulness-Based Cognitive Therapy in the Treatment of Anxiety and Depressive Disorders: A Systematic Review and Meta-analysis.

    Indian Journal of Psychological Medicine · May 1, 2025 Correction notice (opens in new tab)

  74. Pictorial representation of illness and self measure (PRISM): A putative transdiagnostic tool for evaluating therapeutic effects of psychedelic treatments.

    Journal of Psychopharmacology · May 1, 2025 Correction notice (opens in new tab)

  75. Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises

    Molecular Psychiatry · April 26, 2025 Correction notice (opens in new tab)

  76. Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs

    Psychopharmacology · April 23, 2025 Correction notice (opens in new tab)

  77. Racial Differences in Naturalistic Psychedelic Use - Motivations for Use, Communication with Health Care Providers, and Outcomes.

    Journal of Psychoactive Drugs · April 22, 2025 Correction notice (opens in new tab)

  78. Anthropology of Psychedelics

    Anthropology of Consciousness · April 20, 2025 Correction notice (opens in new tab)

  79. Enhanced independence: De-biasing processes in psychedelic research and beyond

    Research Ethics · April 2, 2025 Correction notice (opens in new tab)

  80. Predictors of Recovering Full Consciousness: Results From a Prospective Multisite Italian Study.

    European Journal of Neurology · April 1, 2025 Correction notice (opens in new tab)

  81. Neural mechanisms of psychedelic visual imagery.

    Molecular Psychiatry · April 1, 2025 Correction notice (opens in new tab)

  82. Islam and Psychedelics: An Essay on the Issues of Permissibility and Medical Utility

    Theology and Science · March 20, 2025 Correction notice (opens in new tab)

  83. N-Acetylcysteine Mitigates Ketamine Neurotoxicity in Young Rats by Modulating ROS-Mediated Pyroptosis and Ferroptosis.

    Molecular Neurobiology · March 20, 2025 Correction notice (opens in new tab)

  84. Embodiment in virtual reality: an experiment on how visual and aural First- and Third-person modes affect embodiment and mindfulness

    Virtual Reality · March 14, 2025 Correction notice (opens in new tab)

  85. The Tibetan Traditions of Guides to the Madhyamaka View (dbu ma’i lta khrid): The Schooling of View with Meditation

    Journal of Indian Philosophy · March 14, 2025 Correction notice (opens in new tab)

  86. Connecting brain and mind through temporo-spatial dynamics: Towards a theory of common currency.

    Physics of Life Reviews · March 1, 2025 Correction notice (opens in new tab)

  87. Characterization of Oral Ketamine Use: A Retrospective Review.

    Journal of Pain & Palliative Care Pharmacotherapy · March 1, 2025 Correction notice (opens in new tab)

  88. The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.

    Journal of Affective Disorders · March 1, 2025 Correction notice (opens in new tab)

  89. Maladaptive perfectionism can explain the inverse relationship between dispositional mindfulness and procrastination.

    PLoS One · February 12, 2025 Correction notice (opens in new tab)

  90. Intracranial substrates of meditation-induced neuromodulation in the amygdala and hippocampus.

    Proceedings of the National Academy of Sciences · February 11, 2025 Correction notice (opens in new tab)

  91. The Trouble With Psychedelic Cacti: Conflicting Meanings of San Pedro and Peyote

    Contemporary Drug Problems · February 10, 2025 Correction notice (opens in new tab)

  92. Structural neural plasticity evoked by rapid-acting antidepressant interventions.

    Nature Reviews Neuroscience · February 1, 2025 Correction notice (opens in new tab)

  93. Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial.

    The British Journal of Psychiatry · February 1, 2025 Correction notice (opens in new tab)

  94. The architecture of the human default mode network explored through cytoarchitecture, wiring and signal flow

    Nature Neuroscience · January 28, 2025 Correction notice (opens in new tab)

  95. Exploring Psilocybe cubensis Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps

    Journal of Fungi · January 28, 2025 Correction notice (opens in new tab)

  96. How does meditation relate to quality of life, positive lifestyle habits and carbon footprint?

    Heliyon · January 15, 2025 Correction notice (opens in new tab)

  97. Analysis of self-transcendence status and influencing factors in gastric cancer patients undergoing chemotherapy: a random forest model-based study.

    Frontiers in Psychiatry · 2025 Correction notice (opens in new tab)

  98. Determining the depth of meditation through frontal alpha asymmetry.

    Frontiers in Human Neuroscience · 2025 Correction notice (opens in new tab)

  99. Conscious active inference II: Quantum orchestrated objective reduction among intraneuronal microtubules naturally accounts for discrete perceptual cycles.

    Computational and Structural Biotechnology Journal · 2025 Correction notice (opens in new tab)

  100. Navigating the mainstreaming of psychedelics

    Journal of Psychedelic Studies · 2025 Correction notice (opens in new tab)

  101. Psychedelic Drug Checking: Analytical and Strategic Challenges in Harm Reduction for Classic Psychedelics

    Current Topics in Behavioral Neurosciences · 2025 Correction notice (opens in new tab)

  102. The spiritual core of the hard problem: consciousness as foundational, not emergent.

    Frontiers in Psychology · 2025 Correction notice (opens in new tab)

  103. Supported Mindfulness-Based Self-Help Intervention as an Adjunctive Treatment for Rapid Symptom Change in Emotional Disorders: A Practice-Oriented Multicenter Randomized Controlled Trial.

    Psychotherapy and Psychosomatics · 2025 Correction notice (opens in new tab)

  104. Effectiveness and satisfaction of mindfulness-based cognitive therapy for children on anxiety, depression, and internet addiction in adolescents: Study protocol for a randomized control trial.

    PLoS One · 2025 Correction notice (opens in new tab)

  105. Comparison of the effectiveness of mindfulness-based stress reduction versus cognitive-behavioral therapy on emotion regulation, mindfulness, and cognitive-executive functions in female patients with rheumatoid arthritis.

    Journal of Education and Health Promotion · 2025 Correction notice (opens in new tab)

  106. Mindfulness and self-rated performance among novice athletes in China: a sequential mediating role of flow and cognitive anxiety.

    Frontiers in Psychology · 2025 Correction notice (opens in new tab)

  107. Effects of mindfulness-based interventions on cognitive impairment in patients with cancer: A systematic review and meta-analysis.

    International journal of clinical and health psychology : IJCHP · 2025 Correction notice (opens in new tab)

  108. How does mindfulness training affect attention and penalty kick performance in university football player.

    PLoS One · 2025 Correction notice (opens in new tab)

  109. Rapid treatment center for depression in China: constructive reflections and transnational implications.

    Frontiers in Psychiatry · 2025 Correction notice (opens in new tab)

  110. Navigating groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences.

    PLoS One · 2025 Correction notice (opens in new tab)

  111. Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis

    Clinical Pharmacokinetics · 2025 Correction notice (opens in new tab)

  112. Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.

    Frontiers in Psychiatry · 2025 Correction notice (opens in new tab)

  113. Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.

    Translational Psychiatry · December 4, 2024 Correction notice (opens in new tab)

  114. Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants.

    Neuropsychopharmacology · December 1, 2024 Correction notice (opens in new tab)

  115. Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats.

    Neuropsychopharmacology · December 1, 2024 Correction notice (opens in new tab)

  116. Ayahuasca in the treatment of posttraumatic stress disorder: Mixed-methods case series evaluation in military combat veterans.

    Psychological Trauma: Theory, Research, Practice and Policy · December 1, 2024 Correction notice (opens in new tab)

  117. Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression.

    Neuropsychopharmacology · November 1, 2024 Correction notice (opens in new tab)

  118. Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action

    Current Psychiatry Reports · November 1, 2024 Correction notice (opens in new tab)

  119. Implementation of a community-based LC-UV drug checking service: promising preliminary findings on feasibility and validity.

    Harm Reduction Journal · October 18, 2024 Correction notice (opens in new tab)

  120. Functional activity and connectivity signatures of ketamine and lamotrigine during negative emotional processing: a double-blind randomized controlled fMRI study.

    Translational Psychiatry · October 14, 2024 Correction notice (opens in new tab)

  121. Healing with Ayahuasca the Plant Teacher: Psychedelic Metaphoricity and Polyontologies.

    Medical Anthropology · October 2, 2024 Correction notice (opens in new tab)

  122. Ketamine reduces the neural distinction between self- and other-produced affective touch: a randomized double-blind placebo-controlled study.

    Neuropsychopharmacology · October 1, 2024 Correction notice (opens in new tab)

  123. Ketamine alleviates PTSD-like effect and improves hippocampal synaptic plasticity via regulation of GSK-3β/GR signaling of rats.

    Journal of Psychiatric Research · October 1, 2024 Correction notice (opens in new tab)

  124. Validation of the imperial psychedelic predictor scale.

    Psychological Medicine · September 27, 2024 Correction notice (opens in new tab)

  125. The unpaved road of ayahuasca, a psychoactive brew, as a treatment for neuropathic pain: A review of mechanistic insights and clinical prospects

    Brain Behavior and Immunity Integrative · September 14, 2024 Correction notice (opens in new tab)

  126. Cosmos MIND and matter: Is mind in spacetime?

    Biosystems · September 1, 2024 Correction notice (opens in new tab)

  127. Psilocybin, moralization and psychotherapy: a scoping review and a case report

    Philosophical Psychology · August 20, 2024 Correction notice (opens in new tab)

  128. Mindfulness as a therapeutic option for obsessive-compulsive disorder.

    Expert Review of Neurotherapeutics · August 1, 2024 Correction notice (opens in new tab)

  129. Mediodorsal thalamus and ventral pallidum contribute to subcortical regulation of the default mode network

    Communications Biology · July 23, 2024 Correction notice (opens in new tab)

  130. Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports

    Journal of Psychedelic Studies · July 17, 2024 Correction notice (opens in new tab)

  131. Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.

    Psychopharmacology · July 4, 2024 Correction notice (opens in new tab)

  132. Dynamic regulation of phosphorylation of NMDA receptor GluN2B subunit tyrosine residues mediates ketamine rapid antidepressant effects.

    Pharmacological Research · July 1, 2024 Correction notice (opens in new tab)

  133. Meaningfulness and attachment: what dreams, psychosis and psychedelic states tell us about our need for connection.

    Frontiers in Psychology · June 20, 2024 Correction notice (opens in new tab)

  134. A meta-analysis of the effects of ketamine on suicidal ideation in depression patients.

    Translational Psychiatry · June 10, 2024 Correction notice (opens in new tab)

  135. Forgetting ourselves in flow: an active inference account of flow states and how we experience ourselves within them

    Frontiers in Psychology · June 3, 2024 Correction notice (opens in new tab)

  136. 5-MeO-DMT induces sleep-like LFP spectral signatures in the hippocampus and prefrontal cortex of awake rats.

    Scientific Reports · May 17, 2024 Correction notice (opens in new tab)

  137. An emerging trend in Novel Psychoactive Substances (NPSs): designer THC

    Journal of Cannabis Research · May 3, 2024 Correction notice (opens in new tab)

  138. Predicting non-response to ketamine for depression: An exploratory symptom-level analysis of real-world data among military veterans.

    Psychiatry Research · May 1, 2024 Correction notice (opens in new tab)

  139. Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.

    Naunyn-Schmiedeberg's Archives of Pharmacology · May 1, 2024 Correction notice (opens in new tab)

  140. Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis

    BMJ · May 1, 2024 Correction notice (opens in new tab)

  141. The effects of telehealth-delivered mindfulness meditation, cognitive therapy, and behavioral activation for chronic low back pain: a randomized clinical trial.

    BMC Medicine · April 12, 2024 Correction notice (opens in new tab)

  142. Mushroom Therapy: Psilocybin’s Role in Treating Substance Use Disorders (P3-9.018)

    Neurology · April 9, 2024 Correction notice (opens in new tab)

  143. [Video-Based Online Metta-Meditation Therapy for Depression: A Pilot Trial Evaluating the Acceptability and Feasibility].

    Verhaltenstherapie · April 1, 2024 Correction notice (opens in new tab)

  144. Protocol for a pilot study assessing a virtual mindfulness intervention for postpartum African American women.

    Brain Behavior and Immunity Integrative · April 1, 2024 Correction notice (opens in new tab)

  145. Enhanced amygdala–anterior cingulate white matter structural connectivity in Sahaja Yoga Meditators

    PLoS One · March 28, 2024 Correction notice (opens in new tab)

  146. Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.

    Scientific Reports · March 26, 2024 Correction notice (opens in new tab)

  147. The influence of cultivation conditions on the formation of psychoactive salvinorin A, salvinorin B, rosmarinic acid and caffeic acid in Coleus scutellarioides

    Scientific Reports · March 24, 2024 Correction notice (opens in new tab)

  148. Changes in information integration and brain networks during propofol-, dexmedetomidine-, and ketamine-induced unresponsiveness.

    British Journal of Anaesthesia · March 1, 2024 Correction notice (opens in new tab)

  149. The Mystical Experience Questionnaire 4-Item and Challenging Experience Questionnaire 7-Item.

    Psychedelic Medicine · March 1, 2024 Correction notice (opens in new tab)

  150. Spirituality as a Predictor of Well-Being, Mental Distress or Both: A Four-Week Follow-Up Study in a Sample of Dutch and Belgian Adults

    Religions · February 23, 2024 Correction notice (opens in new tab)

  151. Indigenous psilocybin mushroom practices: An annotated bibliography

    Journal of Psychedelic Studies · February 19, 2024 Correction notice (opens in new tab)

  152. Effects of acute cannabis inhalation on reaction time, decision-making, and memory using a tablet-based application

    Journal of Cannabis Research · February 3, 2024 Correction notice (opens in new tab)

  153. A Comprehensive Descriptive Analysis of Out-of-Session Meditation in a Residential Treatment Setting: Duration, Frequency, and Type of Practice

    Mindfulness · January 13, 2024 Correction notice (opens in new tab)

  154. Ethical considerations in rapid and novel treatments in psychiatry

    Neuropsychopharmacology · 2024 Correction notice (opens in new tab)

  155. Comment on: History repeating: guidelines to address common problems in psychedelic science

    Therapeutic Advances in Psychopharmacology · 2024 Correction notice (opens in new tab)

  156. Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression: A protocol for systematic review and meta-analysis.

    PLoS One · 2024 Correction notice (opens in new tab)

  157. Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.

    Psychological Medicine · 2024 Correction notice (opens in new tab)

  158. Acceptability of psilocybin‐assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis

    Cancer · December 18, 2023 Correction notice (opens in new tab)

  159. [Mind-body medicine in pain management].

    Schmerz (Berlin, Germany) · December 1, 2023 Correction notice (opens in new tab)

  160. Stress-reducing interventions in pregnancy for the prevention of preterm birth: a systematic review and meta-analysis.

    Journal of psychosomatic obstetrics and gynaecology · December 1, 2023 Correction notice (opens in new tab)

  161. The impact of a focused behavioral intervention on brain cannabinoid signaling and interoceptive function: Implications for mood and anxiety

    Brain Behavior and Immunity Integrative · November 30, 2023 Correction notice (opens in new tab)

  162. Psychedelics action and schizophrenia.

    Pharmacological Reports · October 30, 2023 Correction notice (opens in new tab)

  163. Intranasal esketamine as tool for rapid cycling bipolar disorder: A case report of successful mood stabilization

    Psychiatry Research Case Reports · October 18, 2023 Correction notice (opens in new tab)

  164. Sustained antidepressant effect of ketamine through NMDAR trapping in the LHb

    Nature · October 18, 2023 Correction notice (opens in new tab)

  165. Hippocampal subfield volumes in treatment resistant depression and serial ketamine treatment

    Frontiers in Psychiatry · October 9, 2023 Correction notice (opens in new tab)

  166. Epistemic Challenges in Neurophenomenology: Exploring the Reliability of Knowledge and Its Ontological Implications

    Philosophies · October 3, 2023 Correction notice (opens in new tab)

  167. A systematic review of Nightmare prevalence in children.

    Sleep Medicine Reviews · October 1, 2023 Correction notice (opens in new tab)

  168. MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.

    Nature Medicine · October 1, 2023 Correction notice (opens in new tab)

  169. Investigation of advanced mindfulness meditation "cessation" experiences using EEG spectral analysis in an intensively sampled case study.

    Neuropsychologia · September 28, 2023 Correction notice (opens in new tab)

  170. Slower respiration rate is associated with higher self-reported well-being after wellness training

    Scientific Reports · September 24, 2023 Correction notice (opens in new tab)

  171. An empirical investigation of the associations between metacognition, mindfulness experiential avoidance, depression, and anxiety

    BMC Psychology · September 21, 2023 Correction notice (opens in new tab)

  172. Functional vitamin B12 deficiency is a consistent feature in hospital admissions for neurological disorders due to the use of nitrous oxide

    Clinical Toxicology · September 2, 2023 Correction notice (opens in new tab)

  173. Serum BDNF predicts increases in telomere length during a month-long residential meditation retreat

    Brain Behavior and Immunity Integrative · September 1, 2023 Correction notice (opens in new tab)

  174. The effect of ketamine on affective modulation of the startle reflex and its resting-state brain correlates

    Scientific Reports · August 16, 2023 Correction notice (opens in new tab)

  175. Hybrid predictive coding: Inferring, fast and slow

    PLoS Computational Biology · August 2, 2023 Correction notice (opens in new tab)

  176. What is the intention to move and when does it occur?

    Neuroscience & Biobehavioral Reviews · August 2023 Correction notice (opens in new tab)

  177. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report

    Pharmaceuticals · August 1, 2023 Correction notice (opens in new tab)

  178. Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial

    The British Journal of Psychiatry · July 14, 2023 Correction notice (opens in new tab)

  179. A quality improvement study on the feasibility and potential benefits of a yogic breathing program for cancer survivors and caregivers during treatment in a lodging facility.

    Brain Behavior and Immunity Integrative · July 2023 Correction notice (opens in new tab)

  180. New Pharmacologic Approaches to the Treatment of Bipolar Depression.

    Drugs · July 1, 2023 Correction notice (opens in new tab)

  181. Low-Intensity Mindfulness and Cognitive Behavioral Therapy for Social Anxiety Disorder: Pilot Study

    International Journal of Cognitive Therapy · June 30, 2023 Correction notice (opens in new tab)

  182. Long-term benefits of mindfulness on white matter tracts underlying the cortical midline structures in panic disorder: A 2-year longitudinal study.

    Psychiatry and Clinical Neurosciences · June 2023 Correction notice (opens in new tab)

  183. Transpersonal Ecodelia: Surveying Psychedelically Induced Biophilia

    Psychoactives · May 25, 2023 Correction notice (opens in new tab)

  184. Nitrous oxide: a unique official French addictovigilance national survey

    Frontiers in Public Health · May 3, 2023 Correction notice (opens in new tab)

  185. Withania somnifera influences MDMA-induced hyperthermic, cognitive, neurotoxic and neuroinflammatory effects in mice.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · May 1, 2023 Correction notice (opens in new tab)

  186. A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history

    Psychiatry Research Case Reports · April 26, 2023 Correction notice (opens in new tab)

  187. Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trial

    Neuropsychopharmacology · April 19, 2023 Correction notice (opens in new tab)

  188. Source connectivity patterns in the default mode network differ between elderly golf-novices and non-golfers.

    Scientific Reports · April 17, 2023 Correction notice (opens in new tab)

  189. Using an Online-Based Mindfulness Intervention to Reduce Test Anxiety in Physics Students

    Journal of Cognitive Enhancement · April 13, 2023 Correction notice (opens in new tab)

  190. Feasibility and preliminary outcomes of intensive mindfulness and yoga on prisoners with personality disorders: A randomised controlled preliminary study

    Brain Behavior and Immunity Integrative · April 1, 2023 Correction notice (opens in new tab)

  191. Effects of Brief Mindfulness Meditation and Compassion Meditation on Parochial Empathy and Prosocial Behavior Toward Ethnic Out-Group Members.

    Mindfulness · March 27, 2023 Correction notice (opens in new tab)

  192. A novel ego dissolution scale: A construct validation study.

    Consciousness and Cognition · March 1, 2023 Correction notice (opens in new tab)

  193. Exploring Pain, Quality of Life, and Emotional Well-Being in Patients with Advanced Pancreatic Cancer Practicing Spiritual Meditation: A Pilot Study.

    Complementary Medicine Research · February 24, 2023 Correction notice (opens in new tab)

  194. Mindfulness training reduces slippery slope effects in moral decision-making and moral judgment

    Scientific Reports · February 20, 2023 Correction notice (opens in new tab)

  195. Association of the delayed changes in glutamate levels and functional connectivity with the immediate network effects of S-ketamine

    Translational Psychiatry · February 16, 2023 Correction notice (opens in new tab)

  196. A moment of peace: Utilizing practical on the job relaxation and meditation techniques to improve feelings of stress and burnout among healthcare professionals

    Journal of Interprofessional Education & Practice · February 1, 2023 Correction notice (opens in new tab)

  197. Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.

    Journal of Affective Disorders · February 1, 2023 Correction notice (opens in new tab)

  198. Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial.

    EClinicalMedicine · February 1, 2023 Correction notice (opens in new tab)

  199. Effect of blended and unguided online delivery of mindfulness-based cognitive therapy versus care as usual on distress among cancer patients and survivors: protocol for the three-arm parallel randomized controlled buddy trial.

    BMC Psychology · January 25, 2023 Correction notice (opens in new tab)

  200. Creating Coherence in Collective Consciousness for Universal Flourishing: Automatic Self-Transcending for Reducing Conflicts and Improving the Quality of Life in Society

    Palgrave studies in workplace spirituality and fulfillment · 2023 Correction notice (opens in new tab)

  201. Epigenetic, psychological, and EEG changes after a 1-week retreat based on mindfulness and compassion for stress reduction in healthy adults: Study protocol of a cross-over randomized controlled trial.

    PLoS One · 2023 Correction notice (opens in new tab)

  202. Effects of an On‐Campus Meditation Course on Depression, Anxiety, Stress, and Sleep Quality among South Korean Paramedic Students

    Perspectives In Psychiatric Care · 2023 Correction notice (opens in new tab)

  203. Consciousness as the Source of Purposeful Leadership

    Palgrave studies in workplace spirituality and fulfillment · 2023 Correction notice (opens in new tab)

  204. Increases in External Sensory Observing Cross-Sectionally Mediate the Repair of Positive Affect Following Mindfulness-Based Cognitive Therapy in Individuals with Residual Depression Symptoms

    Mindfulness · 2023 Correction notice (opens in new tab)

  205. Doing what matters in times of stress: No-nonsense meditation and occupational well-being in COVID-19.

    PLoS One · 2023 Correction notice (opens in new tab)

  206. History repeating: guidelines to address common problems in psychedelic science

    Therapeutic Advances in Psychopharmacology · 2023 Correction notice (opens in new tab)

  207. Editorial: Working with others’ experience

    Phenomenology and the Cognitive Sciences · December 19, 2022 Correction notice (opens in new tab)

  208. First few seconds for flow: A comprehensive proposal of the neurobiology and neurodynamics of state onset.

    Neuroscience & Biobehavioral Reviews · December 1, 2022 Correction notice (opens in new tab)

  209. A Bayesian Reanalysis of a Trial of Psilocybin Versus Escitalopram for Depression

    Psychedelic Medicine · October 28, 2022 Correction notice (opens in new tab)

  210. Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.

    Neuroimage · October 15, 2022 Correction notice (opens in new tab)

  211. The implementation of an online mindfulness-based program for pediatric patients at a tertiary hospital in South America: a feasibility study protocol.

    Pilot and Feasibility Studies · September 30, 2022 Correction notice (opens in new tab)

  212. What respiratory physicians should know about parasomnias.

    Breathe · September 2022 Correction notice (opens in new tab)

  213. Anterior default mode network and posterior insular connectivity is predictive of depressive symptom reduction following serial ketamine infusion.

    Psychological Medicine · September 1, 2022 Correction notice (opens in new tab)

  214. Examining the Cultural Consensus on Beliefs About Mindfulness Among US College-Attending Young Adults.

    Mindfulness · August 23, 2022 Correction notice (opens in new tab)

  215. Can Rational Emotive Behaviour Therapy (REBT) and Mindfulness be Integrated Effectively within High Performance Settings?

    Journal of Rational-Emotive & Cognitive-Behavior Therapy · August 23, 2022 Correction notice (opens in new tab)

  216. Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data

    Journal of Psychopharmacology · August 16, 2022 Correction notice (opens in new tab)

  217. Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice

    Translational Psychiatry · August 11, 2022 Correction notice (opens in new tab)

  218. A systematic approach to brain dynamics: cognitive evolution theory of consciousness.

    Cognitive Neurodynamics · August 10, 2022 Correction notice (opens in new tab)

  219. A century of 'The science of yoga' (1921-2021): Revival, renewal and renaissance.

    Journal of Ayurveda and Integrative Medicine · August 5, 2022 Correction notice (opens in new tab)

  220. Effect of intensive weekend mindfulness-based intervention on BDNF, mitochondria function, and anxiety. A randomized, crossover clinical trial.

    Comprehensive Psychoneuroendocrinology · August 1, 2022 Correction notice (opens in new tab)

  221. Review of delta‐8‐tetrahydrocannabinol (Δ8‐THC): Comparative pharmacology with Δ9‐THC

    British Journal of Pharmacology · August 1, 2022 Correction notice (opens in new tab)

  222. Phylogenetic Distribution and Trajectories of Visual Consciousness: Examining Feinberg and Mallatt’s Neurobiological Naturalism

    Journal for General Philosophy of Science · July 23, 2022 Correction notice (opens in new tab)

  223. Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial.

    Neuropsychopharmacology · July 2022 Correction notice (opens in new tab)

  224. Difficulties interpreting concentrations in fatal cases: example of 2,5-dimethoxy-4-chloroamphetamine.

    Forensic Toxicology · July 1, 2022 Correction notice (opens in new tab)

  225. Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls

    Scientific Reports · June 30, 2022 Correction notice (opens in new tab)

  226. Ketamine activates adult-born immature granule neurons to rapidly alleviate depression-like behaviors in mice

    Nature Communications · May 12, 2022 Correction notice (opens in new tab)

  227. Informative neural representations of unseen contents during higher-order processing in human brains and deep artificial networks.

    Nature Human Behaviour · May 2022 Correction notice (opens in new tab)

  228. Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trial.

    Progress in Neuro-Psychopharmacology and Biological Psychiatry · May 1, 2022 Correction notice (opens in new tab)

  229. Effect of Mindfulness Versus Loving-kindness Training on Leukocyte Gene Expression in Midlife Adults Raised in Low-Socioeconomic Status Households.

    Mindfulness · May 1, 2022 Correction notice (opens in new tab)

  230. Natural Code of Subjective Experience

    Biosemiotics · May 1, 2022 Correction notice (opens in new tab)

  231. The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age-matched controls

    Psychopharmacology · April 29, 2022 Correction notice (opens in new tab)

  232. A mindfulness-based stress management program for caregivers of allogeneic hematopoietic stem cell transplant (HCT) patients: Protocol for a randomized controlled trial.

    PLoS One · April 1, 2022 Correction notice (opens in new tab)

  233. MDMA and memory, addiction, and depression: dose-effect analysis

    Psychopharmacology · March 1, 2022 Correction notice (opens in new tab)

  234. Enhanced mindfulness-based stress reduction in episodic migraine-effects on sleep quality, anxiety, stress, and depression: a secondary analysis of a randomized clinical trial.

    Pain · March 1, 2022 Correction notice (opens in new tab)

  235. Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review

    Harvard Review of Psychiatry · March 1, 2022 Correction notice (opens in new tab)

  236. Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial

    PLoS One · February 25, 2022 Correction notice (opens in new tab)

  237. Ketamine Psychedelic and Antinociceptive Effects Are Connected

    Anesthesiology · February 21, 2022 Correction notice (opens in new tab)

  238. N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine

    Human Psychopharmacology: Clinical and Experimental · February 17, 2022 Correction notice (opens in new tab)

  239. Microdosing as a Response to the Meaning Crisis: A Qualitative Analysis

    Journal of Humanistic Psychology · February 14, 2022 Correction notice (opens in new tab)

  240. The Role of Executive Function in Children’s Mindfulness Experience

    Mindfulness · February 1, 2022 Correction notice (opens in new tab)

  241. Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT

    Psychopharmacology · January 22, 2022 Correction notice (opens in new tab)

  242. Taking phenomenology beyond the first-person perspective: conceptual grounding in the collection and analysis of observational evidence

    Phenomenology and the Cognitive Sciences · January 9, 2022 Correction notice (opens in new tab)

  243. The effect of mindfulness on the inflammatory, psychological and biomechanical domains of adult patients with low back pain: A randomized controlled clinical trial.

    PLoS One · 2022 Correction notice (opens in new tab)

  244. The Effects of Mindfulness and Buddhist Meditation Coaching on Mental Health Outcomes in College Students.

    Evidence-based Complementary and Alternative Medicine · 2022 Correction notice (opens in new tab)

  245. Protocol for a mobile laboratory study of co-administration of cannabis concentrates with a standard alcohol dose in humans.

    PLoS One · 2022 Correction notice (opens in new tab)

  246. Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.

    Psychopharmacology · 2022 Correction notice (opens in new tab)

  247. Dose-response Relationship of Reported Lifetime Meditation Practice with Mental Health and Wellbeing: a Cross-sectional Study.

    Mindfulness · 2022 Correction notice (opens in new tab)

  248. Pharmacokinetic, pharmacodynamic, and behavioural studies of deschloroketamine in Wistar rats.

    British Journal of Pharmacology · 2022 Correction notice (opens in new tab)

  249. Theta Neurofeedback Training Supports Motor Performance and Flow Experience.

    Journal of Cognitive Enhancement · 2022 Correction notice (opens in new tab)

  250. Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review

    BJPsych Open · December 23, 2021 Correction notice (opens in new tab)

  251. A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development

    Frontiers in Psychiatry · December 7, 2021 Correction notice (opens in new tab)

  252. Evolutionary Origin and the Development of Consciousness.

    Neuroscience & Biobehavioral Reviews · December 1, 2021 Correction notice (opens in new tab)

  253. Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine

    Molecular Psychiatry · November 24, 2021 Correction notice (opens in new tab)

  254. Mindfulness-Based Intervention for Children with Mental Health Problems: a 2-Year Follow-up Randomized Controlled Study

    Mindfulness · October 16, 2021 Correction notice (opens in new tab)

  255. Looking from within: Comparing first-person approaches to studying experience

    Current Psychology · September 30, 2021 Correction notice (opens in new tab)

  256. A Qualitative Exploration of Relational Ethical Challenges and Practices in Psychedelic Healing

    Journal of Humanistic Psychology · September 16, 2021 Correction notice (opens in new tab)

  257. Safety pharmacology of acute LSD administration in healthy subjects

    Psychopharmacology · September 13, 2021 Correction notice (opens in new tab)

  258. The Role of Psilocybin-Assisted Psychotherapy to Support Patients With Cancer: A Critical Scoping Review of the Research

    Journal of Holistic Nursing · September 6, 2021 Correction notice (opens in new tab)

  259. Gradedness of visual awareness depends on attentional scope: Global perception is more graded than local perception.

    Consciousness and Cognition · September 2021 Correction notice (opens in new tab)

  260. Number processing outside awareness? Systematically testing sensitivities of direct and indirect measures of consciousness.

    Attention, Perception & Psychophysics · August 2021 Correction notice (opens in new tab)

  261. R (-)-methoxetamine exerts rapid and sustained antidepressant effects and fewer behavioral side effects relative to S (+)-methoxetamine.

    Neuropharmacology · August 1, 2021 Correction notice (opens in new tab)

  262. Psychedelics for Brain Injury: A Mini-Review.

    Frontiers in Neurology · July 29, 2021 Correction notice (opens in new tab)

  263. Free association in psychoanalysis and its links to neuroscience contributions

    Neuropsychoanalysis · July 3, 2021 Correction notice (opens in new tab)

  264. The Effects of Mindfulness Meditation on Stress and Burnout in Nurses

    Journal of Holistic Nursing · May 17, 2021 Correction notice (opens in new tab)

  265. MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers

    Trials · April 23, 2021 Correction notice (opens in new tab)

  266. New designer phenethylamines 2C-C and 2C-P have abuse potential and induce neurotoxicity in rodents.

    Archives of Toxicology · April 1, 2021 Correction notice (opens in new tab)

  267. Exploring the Relationship Between Character Strengths and Meditation: a Cross-Sectional Study Among Long-Term Practitioners of Sahaja Yoga Meditation

    International Journal of Applied Positive Psychology · March 31, 2021 Correction notice (opens in new tab)

  268. Spiritual well-being, self-transcendence, and spiritual practices among Filipino women with breast cancer

    Palliative & Supportive Care · March 8, 2021 Correction notice (opens in new tab)

  269. Sociological investigations of human enhancement drugs: The case of microdosing psychedelics

    International Journal of Drug Policy · January 28, 2021 Correction notice (opens in new tab)

  270. The Minimal Phenomenal Experience questionnaire (MPE-92M): Towards a phenomenological profile of "pure awareness" experiences in meditators.

    PLoS One · 2021 Correction notice (opens in new tab)

  271. Four Element Meditation

    Mindfulness · 2021 Correction notice (opens in new tab)

  272. Making "bad trips" good: How users of psychedelics narratively transform challenging trips into valuable experiences.

    International Journal of Drug Policy · 2021 Correction notice (opens in new tab)

  273. Mindfulness in the OR: A Pilot Study Investigating the Efficacy of an Abbreviated Mindfulness Intervention on Improving Performance in the Operating Room.

    Journal of surgical education · 2021 Correction notice (opens in new tab)

  274. Evaluation of the Cytotoxicity of Ayahuasca Beverages

    Molecules · November 28, 2020 Correction notice (opens in new tab)

  275. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L’humeur Et De L’anxiété (Canmat) Concernant L’utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur

    The Canadian Journal of Psychiatry · November 11, 2020 Correction notice (opens in new tab)

  276. A causal role for the right angular gyrus in self-location mediated perspective taking.

    Scientific Reports · November 5, 2020 Correction notice (opens in new tab)

  277. Investigating the effect of transcendental meditation on spiritual wellbeing of Type-2 diabetic amputees: A clinical trial study.

    Heliyon · November 1, 2020 Correction notice (opens in new tab)

  278. Once Again on External Mindfulness

    Mindfulness · November 1, 2020 Correction notice (opens in new tab)

  279. DMT alters cortical travelling waves.

    Elife · October 12, 2020 Correction notice (opens in new tab)

  280. Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention

    Journal of Psychopharmacology · October 8, 2020 Correction notice (opens in new tab)

  281. Mediational pathways of meditation and exercise on mental health and perceived stress: A randomized controlled trial.

    Journal of Health Psychology · October 2020 Correction notice (opens in new tab)

  282. Cellular Mechanisms of Conscious Processing.

    Trends in Cognitive Sciences · October 2020 Correction notice (opens in new tab)

  283. Confronting Racism with Mindfulness

    Mindfulness · October 1, 2020 Correction notice (opens in new tab)

  284. Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis

    Journal of Affective Disorders · September 23, 2020 Correction notice (opens in new tab)

  285. Endogenous theta stimulation during meditation predicts reduced opioid dosing following treatment with Mindfulness-Oriented Recovery Enhancement.

    Neuropsychopharmacology · September 12, 2020 Correction notice (opens in new tab)

  286. Meditation Maps, Attainment Claims, and the Adversities of Mindfulness

    Mindfulness · September 1, 2020 Correction notice (opens in new tab)

  287. Broadband slow-wave modulation in posterior and anterior cortex tracks distinct states of propofol-induced unconsciousness.

    Scientific Reports · August 13, 2020 Correction notice (opens in new tab)

  288. The Centrality of Mindfulness-Related Meditations in Early Buddhist Discourse

    Mindfulness · August 1, 2020 Correction notice (opens in new tab)

  289. In vitro structure–activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor

    Archives of Toxicology · July 5, 2020 Correction notice (opens in new tab)

  290. External Mindfulness

    Mindfulness · July 1, 2020 Correction notice (opens in new tab)

  291. A Phenomenological Paradigm for Empirical Research in Psychiatry and Psychology: Open Questions

    Frontiers in Psychology · June 25, 2020 Correction notice (opens in new tab)

  292. Thinking embodiment with genetics: epigenetics and postgenomic biology in embodied cognition and enactivism

    Synthese · June 18, 2020 Correction notice (opens in new tab)

  293. Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence

    Expert Opinion on Drug Safety · June 15, 2020 Correction notice (opens in new tab)

  294. Somatics of Early Buddhist Mindfulness and How to Face Anxiety

    Mindfulness · June 1, 2020 Correction notice (opens in new tab)

  295. Chronic pain and psychedelics: a review and proposed mechanism of action

    Regional Anesthesia & Pain Medicine · May 4, 2020 Correction notice (opens in new tab)

  296. Designer drugs: mechanism of action and adverse effects

    Archives of Toxicology · April 1, 2020 Correction notice (opens in new tab)

  297. Psychedelic Birth: Bodies, Boundaries and the Perception of Pain in the 1970s

    Gender & History · March 1, 2020 Correction notice (opens in new tab)

  298. Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats

    Metabolic Brain Disease · February 27, 2020 Correction notice (opens in new tab)

  299. Mystical and Other Alterations in Sense of Self: An Expanded Framework for Studying Nonordinary Experiences

    Perspectives on Psychological Science · February 13, 2020 Correction notice (opens in new tab)

  300. Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity

    Biological Psychiatry · January 13, 2020 Correction notice (opens in new tab)

  301. Study protocol for a randomized control trial to investigate the effectiveness of an 8-week mindfulness-integrated cognitive behavior therapy (MiCBT) transdiagnostic group intervention for primary care patients.

    BMC Psychiatry · January 6, 2020 Correction notice (opens in new tab)

  302. Meditation effect in changing functional integrations across large-scale brain networks: Preliminary evidence from a meta-analysis of seed-based functional connectivity

    Journal of Pacific Rim Psychology · 2020 Correction notice (opens in new tab)

  303. Distinguishing volumetric content from perceptual presence within a predictive processing framework.

    Phenomenology and the Cognitive Sciences · 2020 Correction notice (opens in new tab)

  304. Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment

    Psychopharmacology · December 10, 2019 Correction notice (opens in new tab)

  305. An integrative framework for perceptual disturbances in psychosis.

    Nature Reviews Neuroscience · December 2019 Correction notice (opens in new tab)

  306. Bayesian adaptive randomization trial of intravenous ketamine for veterans with late-life, treatment-resistant depression.

    Contemporary Clinical Trials Communications · December 1, 2019 Correction notice (opens in new tab)

  307. The Altered States of Consciousness in Transpersonal Approach Psychotherapy: Systematic Review and Guidelines for Research and Clinical Practice.

    Journal of Religion and Health · December 1, 2019 Correction notice (opens in new tab)

  308. Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial.

    BMC Psychiatry · November 29, 2019 Correction notice (opens in new tab)

  309. Effectiveness of mindfulness‐based cognitive therapy in patients with anxiety disorders in secondary‐care settings: A randomized controlled trial

    Psychiatry and Clinical Neurosciences · November 27, 2019 Correction notice (opens in new tab)

  310. Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials

    Australian & New Zealand Journal of Psychiatry · November 15, 2019 Correction notice (opens in new tab)

  311. The Effect of Brief Mindfulness Training on Brain Reactivity to Food Cues During Nicotine Withdrawal: A Pilot Functional Imaging Study.

    Mindfulness · November 2019 Correction notice (opens in new tab)

  312. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: A systematic review and meta-analysis

    The Lancet Psychiatry · October 28, 2019 Correction notice (opens in new tab)

  313. Extinction training following cocaine or MDMA self-administration produces discrete changes in D2-like and mGlu5 receptor density in the rat brain.

    Pharmacological Reports · October 2019 Correction notice (opens in new tab)

  314. Loving-kindness meditation slows biological aging in novices: Evidence from a 12-week randomized controlled trial.

    Psychoneuroendocrinology · October 1, 2019 Correction notice (opens in new tab)

  315. Differential sensitivity of mindfulness questionnaires to change with treatment: A systematic review and meta-analysis.

    Psychological Assessment · August 1, 2019 Correction notice (opens in new tab)

  316. New/emerging psychoactive substances and associated psychopathological consequences

    Psychological Medicine · July 22, 2019 Correction notice (opens in new tab)

  317. Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose.

    Pharmacological Reviews · July 1, 2019 Correction notice (opens in new tab)

  318. Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines

    Nature Communications · June 3, 2019 Correction notice (opens in new tab)

  319. The differentiation of 2,5-dimethoxy-N-(N-methoxybenzyl)phenethylamine (NBOMe) isomers using GC retention indices and multivariate analysis of ion abundances in electron ionization mass spectra

    Forensic Chemistry · June 1, 2019 Correction notice (opens in new tab)

  320. Twirling Triplets: The Qualia of Rotation and Musical Rhythm

    Music & Science · May 15, 2019 Correction notice (opens in new tab)

  321. On the "blindness" of blindsight: What is the evidence for phenomenal awareness in the absence of primary visual cortex (V1)?

    Neuropsychologia · May 1, 2019 Correction notice (opens in new tab)

  322. Principles for a Responsible Integration of Mindfulness in Individual Therapy

    Mindfulness · April 29, 2019 Correction notice (opens in new tab)

  323. Metabolite Profiling of Anti-Addictive Alkaloids from Four Mexican Tabernaemontana Species and the Entheogenic African Shrub Tabernanthe iboga (Apocynaceae).

    Chemistry & Biodiversity · April 1, 2019 Correction notice (opens in new tab)

  324. Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)

    Psychopharmacology · February 14, 2019 Correction notice (opens in new tab)

  325. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

    Neuropsychopharmacology · January 26, 2019 Correction notice (opens in new tab)

  326. Arguments for a Phenomenologically Informed Clinical Approach to Autism Spectrum Disorder.

    Psychopathology · 2019 Correction notice (opens in new tab)

  327. The Easy Part of the Hard Problem: A Resonance Theory of Consciousness.

    Frontiers in Human Neuroscience · 2019 Correction notice (opens in new tab)

  328. Mass poisoning with NPS: 2C-E and Bromo-DragonFly.

    International Journal of Legal Medicine · 2019 Correction notice (opens in new tab)

  329. Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion.

    Journal of Affective Disorders · December 1, 2018 Correction notice (opens in new tab)

  330. The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial

    Psychopharmacology · November 26, 2018 Correction notice (opens in new tab)

  331. Quality of maternal behaviour during infancy predicts functional connectivity between default mode network and salience network 9 years later.

    Developmental Cognitive Neuroscience · November 2018 Correction notice (opens in new tab)

  332. A Model of Δ9-Tetrahydrocannabinol Self-administration and Reinstatement That Alters Synaptic Plasticity in Nucleus Accumbens.

    Biological Psychiatry · October 15, 2018 Correction notice (opens in new tab)

  333. Double-Blind, Placebo-Controlled, Dose-Ranging Trial of Intravenous Ketamine as Adjunctive Therapy in Treatment-Resistant Depression (TRD)

    Molecular Psychiatry · October 3, 2018 Correction notice (opens in new tab)

  334. Mindfulness-based stress reduction in middle-aged and older adults with memory complaints: a mixed-methods study.

    Aging & Mental Health · September 2018 Correction notice (opens in new tab)

  335. Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study.

    Journal of Child and Adolescent Psychopharmacology · September 2018 Correction notice (opens in new tab)

  336. Default mode network can support the level of detail in experience during active task states

    Proceedings of the National Academy of Sciences · August 27, 2018 Correction notice (opens in new tab)

  337. Calcium/Calmodulin-Dependent Protein Kinase II and Eukaryotic Elongation Factor 2 Kinase Pathways Mediate the Antidepressant Action of Ketamine.

    Biological Psychiatry · July 1, 2018 Correction notice (opens in new tab)

  338. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms

    Pharmacological Reviews · June 26, 2018 Correction notice (opens in new tab)

  339. The prestimulus default mode network state predicts cognitive task performance levels on a mental rotation task.

    Brain and Behavior · June 22, 2018 Correction notice (opens in new tab)

  340. Insight meditation and telomere biology: The effects of intensive retreat and the moderating role of personality.

    Brain, Behavior, and Immunity · May 1, 2018 Correction notice (opens in new tab)

  341. Reduced interference in working memory following mindfulness training is associated with increases in hippocampal volume

    Brain Imaging and Behavior · March 17, 2018 Correction notice (opens in new tab)

  342. Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model.

    Scientific Reports · March 5, 2018 Correction notice (opens in new tab)

  343. Slime mould: The fundamental mechanisms of biological cognition.

    Biosystems · March 2018 Correction notice (opens in new tab)

  344. The Effects of Cariprazine and Aripiprazole on PCP-Induced Deficits on Attention Assessed in the 5-Choice Serial Reaction Time Task

    Psychopharmacology · February 22, 2018 Correction notice (opens in new tab)

  345. REM sleep respiratory behaviours mental content in narcoleptic lucid dreamers.

    Scientific Reports · February 8, 2018 Correction notice (opens in new tab)

  346. Hallucinations, neuroplasticity, and prediction errors in schizophrenia.

    Scandinavian Journal of Psychology · February 1, 2018 Correction notice (opens in new tab)

  347. The hidden therapist: evidence for a central role of music in psychedelic therapy

    Psychopharmacology · February 1, 2018 Correction notice (opens in new tab)

  348. Income change alters default mode network connectivity for adolescents in poverty

    Developmental Cognitive Neuroscience · January 31, 2018 Correction notice (opens in new tab)

  349. The importance of awareness for understanding language.

    Journal of Experimental Psychology General · January 25, 2018 Correction notice (opens in new tab)

  350. Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder.

    Journal of Contemporary Psychotherapy · January 6, 2018 Correction notice (opens in new tab)

  351. Mindfulness-related differences in neural response to own infant negative versus positive emotion contexts.

    Developmental Cognitive Neuroscience · January 5, 2018 Correction notice (opens in new tab)

  352. Mindfulness-Based Cognitive Therapy for Young People and Their Carers: a Mixed-Method Feasibility Study.

    Mindfulness · 2018 Correction notice (opens in new tab)

  353. Understanding changes in dyspnoea perception in obstructive lung disease after mindfulness training.

    BMJ open respiratory research · 2018 Correction notice (opens in new tab)

  354. Meditation-induced neuroplastic changes of the prefrontal network are associated with reduced valence perception in older people.

    Brain and Neuroscience Advances · 2018 Correction notice (opens in new tab)

  355. Mechanistic Target of Rapamycin-Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model.

    Biological Psychiatry · 2018 Correction notice (opens in new tab)

  356. Lessons for the Health-care Practitioner from Buddhism.

    Indian journal of endocrinology and metabolism · 2018 Correction notice (opens in new tab)

  357. Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression.

    Neuropsychopharmacology · December 2017 Correction notice (opens in new tab)

  358. Brief training in mindfulness meditation reduces symptoms in patients with a chronic or recurrent lifetime history of depression: A randomized controlled study.

    Behaviour Research and Therapy · December 1, 2017 Correction notice (opens in new tab)

  359. Measuring inhibition of monoamine reuptake transporters by new psychoactive substances (NPS) in real-time using a high-throughput, fluorescence-based assay.

    Toxicology in Vitro · December 1, 2017 Correction notice (opens in new tab)

  360. Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey

    Scientific Reports · November 3, 2017 Correction notice (opens in new tab)

  361. Characteristics of the memory sources of dreams: A new version of the content-matching paradigm to take mundane and remote memories into account

    PLoS One · October 11, 2017 Correction notice (opens in new tab)

  362. Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis use

    Brain and Behavior · October 6, 2017 Correction notice (opens in new tab)

  363. Binocular rivalry after right-hemisphere stroke: Effects of attention impairment on perceptual dominance patterns.

    Brain and Cognition · October 2017 Correction notice (opens in new tab)

  364. Treadmill exercise alters ecstasy- induced long- term potentiation disruption in the hippocampus of male rats.

    Metabolic Brain Disease · October 2017 Correction notice (opens in new tab)

  365. Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association.

    Journal of the American Heart Association · September 28, 2017 Correction notice (opens in new tab)

  366. Ketamine: New Use for an Old Hat

    Journal of Clinical Anesthesia and Pain Management · September 22, 2017 Correction notice (opens in new tab)

  367. MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor

    Psychopharmacology · July 22, 2017 Correction notice (opens in new tab)

  368. Mindfulness and compassion-oriented practices at work reduce distress and enhance self-care of palliative care teams: a mixed-method evaluation of an “on the job“ program

    BMC Palliative Care · July 6, 2017 Correction notice (opens in new tab)

  369. Urban atmospheres.

    Cultural geographies · July 1, 2017 Correction notice (opens in new tab)

  370. The psychoactive drug 25B-NBOMe recapitulates rhabdomyolysis in zebrafish larvae

    Forensic Toxicology · July 1, 2017 Correction notice (opens in new tab)

  371. Yoga, Meditation and Mind-Body Health: Increased BDNF, Cortisol Awakening Response, and Altered Inflammatory Marker Expression after a 3-Month Yoga and Meditation Retreat

    Frontiers in Human Neuroscience · June 26, 2017 Correction notice (opens in new tab)

  372. Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications

    Scientific Reports · April 27, 2017 Correction notice (opens in new tab)

  373. Brain changes during a shamanic trance: Altered modes of consciousness, hemispheric laterality, and systemic psychobiology

    Cogent Psychology · April 24, 2017 Correction notice (opens in new tab)

  374. Meditation and Cognitive Ageing: the Role of Mindfulness Meditation in Building Cognitive Reserve

    Journal of Cognitive Enhancement · April 12, 2017 Correction notice (opens in new tab)

  375. An international multi-site, randomized controlled trial of a mindfulness-based psychoeducation group programme for people with schizophrenia

    Psychological Medicine · April 4, 2017 Correction notice (opens in new tab)

  376. Collective intentionality and socially extended minds

    Philosophical Psychology · April 3, 2017 Correction notice (opens in new tab)

  377. Extreme rituals in a BDSM context: the physiological and psychological effects of the 'Dance of Souls'.

    Culture, health & sexuality · April 1, 2017 Correction notice (opens in new tab)

  378. Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands.

    Addiction · April 1, 2017 Correction notice (opens in new tab)

  379. Genetic Correlates of Spirituality/Religion and Depression: A Study in Offspring and Grandchildren at High and Low Familial Risk for Depression.

    Spirituality in Clinical Practice · March 1, 2017 Correction notice (opens in new tab)

  380. Administration of ketamine for unipolar and bipolar depression.

    International Journal of Psychiatry in Clinical Practice · March 2017 Correction notice (opens in new tab)

  381. Analytically diagnosed intoxication by 2-methoxphenidine and flubromazepam mimicking an ischemic cerebral disease

    Clinical Toxicology · February 8, 2017 Correction notice (opens in new tab)

  382. Impact of Yoga and Meditation on Cellular Aging in Apparently Healthy Individuals: A Prospective, Open-Label Single-Arm Exploratory Study

    Oxidative Medicine and Cellular Longevity · January 16, 2017 Correction notice (opens in new tab)

  383. Implementing Mindfulness in the Mainstream: Making the Path by Walking It.

    Mindfulness · 2017 Correction notice (opens in new tab)

  384. Continuation phase intravenous ketamine in adults with treatment-resistant depression.

    Journal of Affective Disorders · December 2016 Correction notice (opens in new tab)

  385. Biosynthesis of the psychotropic plant diterpene salvinorin A: Discovery and characterization of the Salvia divinorum clerodienyl diphosphate synthase

    The Plant Journal · November 19, 2016 Correction notice (opens in new tab)

  386. Grounding, conceivability, and the mind-body problem

    Synthese · November 8, 2016 Correction notice (opens in new tab)

  387. Hallucinatory experience as aberrant event memory formation: Implications for the pathophysiology of schizophrenia.

    Progress in Neuro-Psychopharmacology and Biological Psychiatry · November 3, 2016 Correction notice (opens in new tab)

  388. Contemplative Practice: Philosophy, Pedagogy, and Science

    October 24, 2016 Correction notice (opens in new tab)

  389. The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux

    Biochemical Pharmacology · September 13, 2016 Correction notice (opens in new tab)

  390. The experience of meditation for people with amyotrophic lateral sclerosis and their caregivers - a qualitative analysis.

    Psychology, Health & Medicine · September 2016 Correction notice (opens in new tab)

  391. Psychosis associated with acute recreational drug toxicity: a European case series.

    BMC Psychiatry · August 18, 2016 Correction notice (opens in new tab)

  392. Phenomenological Fingerprints of Four Meditations: Differential State Changes in Affect, Mind-Wandering, Meta-Cognition, and Interoception Before and After Daily Practice Across 9 Months of Training

    Mindfulness · August 18, 2016 Correction notice (opens in new tab)

  393. Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors.

    Psychopharmacology · August 2016 Correction notice (opens in new tab)

  394. Long-term follow-up of psilocybin-facilitated smoking cessation

    The American Journal of Drug and Alcohol Abuse · July 21, 2016 Correction notice (opens in new tab)

  395. How to make the ghosts in my bedroom disappear? Focused-attention meditation combined with muscle relaxation (MR therapy)—a direct treatment intervention for sleep paralysis

    Frontiers in Psychology · July 4, 2016 Correction notice (opens in new tab)

  396. AVPR1a and SLC6A4 gene polymorphisms are associated with creative dance performance.

    PLoS Genetics · June 14, 2016 Correction notice (opens in new tab)

  397. The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor.

    PLoS One · June 14, 2016 Correction notice (opens in new tab)

  398. Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine.

    Psychiatry Research · May 30, 2016 Correction notice (opens in new tab)

  399. Cannabis and tolerance: acute drug impairment as a function of cannabis use history

    Scientific Reports · May 26, 2016 Correction notice (opens in new tab)

  400. Is dream recall underestimated by retrospective measures and enhanced by keeping a logbook? An empirical investigation.

    Consciousness and Cognition · May 1, 2016 Correction notice (opens in new tab)

  401. Mindfulness Enhances Episodic Memory Performance: Evidence from a Multimethod Investigation

    PLoS One · April 26, 2016 Correction notice (opens in new tab)

  402. Neural correlates of consciousness: progress and problems

    Nature Reviews Neuroscience · April 20, 2016 Correction notice (opens in new tab)

  403. Drugged Subjectivity, Intoxicating Alterity

    Anthropology of Consciousness · March 2, 2016 Correction notice (opens in new tab)

  404. Regional brain dysregulation of Ca2+-handling systems in ketamine-induced rat model of experimental psychosis

    Cell and tissue research · December 21, 2015 Correction notice (opens in new tab)

  405. Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans.

    Drug and Alcohol Dependence · December 1, 2015 Correction notice (opens in new tab)

  406. Effects of a Mindfulness Meditation Course on Learning and Cognitive Performance among University Students in Taiwan.

    Evidence-based Complementary and Alternative Medicine · November 10, 2015 Correction notice (opens in new tab)

  407. Novel Glutamatergic Treatments for Severe Mood Disorders.

    Current behavioral neuroscience reports · October 9, 2015 Correction notice (opens in new tab)

  408. A randomized controlled trial on the efficacy of mindfulness-based cognitive therapy and a group version of cognitive behavioral analysis system of psychotherapy for chronically depressed patients.

    Journal of Consulting and Clinical Psychology · October 2015 Correction notice (opens in new tab)

  409. Schizophrenia Patient or Spiritually Advanced Personality? A Qualitative Case Analysis.

    Journal of Religion and Health · October 1, 2015 Correction notice (opens in new tab)

  410. R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects

    Translational Psychiatry · September 1, 2015 Correction notice (opens in new tab)

  411. Light microscopy can reveal the consumption of a mixture of psychotropic plant and fungal material in suspicious death.

    Journal of Forensic and Legal Medicine · August 1, 2015 Correction notice (opens in new tab)

  412. Mindfulness in cultural context

    Transcultural Psychiatry · August 1, 2015 Correction notice (opens in new tab)

  413. Is meditation always relaxing? Investigating heart rate, heart rate variability, experienced effort and likeability during training of three types of meditation.

    International Journal of Psychophysiology · July 1, 2015 Correction notice (opens in new tab)

  414. More Meditation, Less Habituation? The Effect of Mindfulness Practice on the Acoustic Startle Reflex

    PLoS One · May 6, 2015 Correction notice (opens in new tab)

  415. Is dream recall underestimated by retrospective measures and enhanced by keeping a logbook? A review.

    Consciousness and Cognition · May 1, 2015 Correction notice (opens in new tab)

  416. Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review

    Therapeutic Advances in Chronic Disease · April 13, 2015 Correction notice (opens in new tab)

  417. Recruitment of the default mode network during a demanding act of executive control

    Elife · April 13, 2015 Correction notice (opens in new tab)

  418. Comparison of the acceptability and benefits of two mindfulness-based interventions in women with breast or gynecologic cancer: a pilot study.

    Supportive Care in Cancer · April 2015 Correction notice (opens in new tab)

  419. How do mindfulness-based cognitive therapy and mindfulness-based stress reduction improve mental health and wellbeing? A systematic review and meta-analysis of mediation studies.

    Clinical Psychology Review · April 1, 2015 Correction notice (opens in new tab)

  420. The Relationship between Bipolar Disorder and Cannabis Use in Daily Life: An Experience Sampling Study

    PLoS One · March 4, 2015 Correction notice (opens in new tab)

  421. The wandering brain: Meta-analysis of functional neuroimaging studies of mind-wandering and related spontaneous thought processes

    Neuroimage · February 25, 2015 Correction notice (opens in new tab)

  422. Interaction between neuroanatomical and psychological changes after mindfulness-based training.

    PLoS One · October 20, 2014 Correction notice (opens in new tab)

  423. Information integration without awareness.

    Trends in Cognitive Sciences · September 2014 Correction notice (opens in new tab)

  424. Yoga and meditation in cardiovascular disease.

    Clinical research in cardiology : official journal of the German Cardiac Society · September 1, 2014 Correction notice (opens in new tab)

  425. Schizophrenia or possession?

    Journal of Religion and Health · June 1, 2014 Correction notice (opens in new tab)

  426. Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway.

    Molecular Psychiatry · April 2014 Correction notice (opens in new tab)

  427. Effectiveness of a worksite mindfulness-related multi-component health promotion intervention on work engagement and mental health: results of a randomized controlled trial.

    PLoS One · January 28, 2014 Correction notice (opens in new tab)

  428. Protective effects of N-acetylcysteine on 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in male Sprague-Dawley rats.

    Metabolic Brain Disease · December 2013 Correction notice (opens in new tab)

  429. Δ9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling.

    Cell · November 21, 2013 Correction notice (opens in new tab)

  430. Sex-Dependent Psychoneuroendocrine Effects of THC and MDMA in an Animal Model of Adolescent Drug Consumption

    PLoS One · November 4, 2013 Correction notice (opens in new tab)

  431. How positive emotions build physical health: perceived positive social connections account for the upward spiral between positive emotions and vagal tone.

    Psychological Science · July 1, 2013 Correction notice (opens in new tab)

  432. Rhythmic alternating patterns of brain activity distinguish rapid eye movement sleep from other states of consciousness.

    Proceedings of the National Academy of Sciences · June 18, 2013 Correction notice (opens in new tab)

  433. Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans.

    Drug and Alcohol Dependence · March 1, 2013 Correction notice (opens in new tab)

  434. Impaired executive functions in subjects with frequent nightmares as reflected by performance in different neuropsychological tasks.

    Brain and Cognition · April 1, 2012 Correction notice (opens in new tab)

  435. Treatment-specific changes in decentering following mindfulness-based cognitive therapy versus antidepressant medication or placebo for prevention of depressive relapse.

    Journal of Consulting and Clinical Psychology · March 12, 2012 Correction notice (opens in new tab)

  436. Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study.

    Neuropsychopharmacology · June 2011 Correction notice (opens in new tab)

  437. Magical flight and monstrous stress: technologies of absorption and mental wellness in Azeroth.

    Culture, medicine and psychiatry · March 2011 Correction notice (opens in new tab)

  438. What about 'information'?

    EMBO Reports · February 2011 Correction notice (opens in new tab)

  439. The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.

    Journal of Psychopharmacology · July 19, 2010 Correction notice (opens in new tab)

  440. Quantum information, oscillations and the psyche

    Physics of Particles and Nuclei · May 1, 2010 Correction notice (opens in new tab)

  441. Minding one’s emotions: Mindfulness training alters the neural expression of sadness.

    Emotion · February 1, 2010 Correction notice (opens in new tab)

  442. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.

    Addiction · January 2010 Correction notice (opens in new tab)

  443. Psychedelics and the Human Receptorome

    PLoS One · 2010 Correction notice (opens in new tab)

  444. The Neural Correlates of Religious and Nonreligious Belief

    PLoS One · September 30, 2009 Correction notice (opens in new tab)

  445. Sensory Gating Impairments in Heavy Cannabis Users are Associated with Altered Neural Oscillations

    Behavioral Neuroscience · August 1, 2009 Correction notice (opens in new tab)

  446. Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats.

    Neuropsychopharmacology · October 2008 Correction notice (opens in new tab)

  447. Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues.

    Bioorganic & Medicinal Chemistry Letters · November 1, 2006 Correction notice (opens in new tab)

  448. Synthesis and in vitro evaluation of salvinorin A analogues: effect of configuration at C(2) and substitution at C(18).

    Bioorganic & Medicinal Chemistry Letters · September 1, 2006 Correction notice (opens in new tab)

  449. Transcranial magnetic stimulation of the visual cortex induces somatotopically organized qualia in blind subjects.

    Proceedings of the National Academy of Sciences of the United States of America · August 17, 2006 Correction notice (opens in new tab)

  450. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

    Proceedings of the National Academy of Sciences · December 13, 2005 Correction notice (opens in new tab)

  451. An analysis of recent meditation research and suggestions for future directions.

    The Humanistic Psychologist · 2003 Correction notice (opens in new tab)

  452. Psychedelic Therapy: A Primer for Primary Care Clinicians-N,N-Dimethyltryptamine and Ayahuasca.

    American Journal of Therapeutics Correction notice (opens in new tab)

Discussed on PubPeer 117

Readers have posted post-publication comments; a comment is not a verdict.

  1. Perception as self-organizing interaction: embodied cognition, artificial intelligence, and autism.

    Frontiers in Psychology · March 30, 2026 2 comments on PubPeer (opens in new tab)

  2. Exploring Colombian medicinal flora used in indigenous and campesino health systems for neuropsychiatric disorders and neuropharmacological potential: an ethnopharmacological review

    Frontiers in Pharmacology · March 11, 2026 2 comments on PubPeer (opens in new tab)

  3. Sex differences in placebo and antidepressant response to intranasal esketamine for treatment-resistant depression

    Molecular Psychiatry · February 18, 2026 1 comment on PubPeer (opens in new tab)

  4. The consciousness spectrum: the emergent nature of purpose, memory, and adaptive response across organisms, humans, and technological beings

    Frontiers in Computer Science · February 4, 2026 2 comments on PubPeer (opens in new tab)

  5. N,N-Diisopropyltryptamine and diptogenia: proposed mechanisms for a frequency-selective pitch-distorting psychedelic.

    Brain Communications · 2026 2 comments on PubPeer (opens in new tab)

  6. Transient multidomain functional improvement in advanced Alzheimer's disease following high-dose psilocybin-containing mushroom administration: a case report.

    Frontiers in Neuroscience · 2026 3 comments on PubPeer (opens in new tab)

  7. Next-Generation MDMA Analogue SDMA: Pharmacological and Metabolic Insights

    ACS Chemical Neuroscience · December 2, 2025 3 comments on PubPeer (opens in new tab)

  8. Neural and molecular changes during a mind-body reconceptualization, meditation, and open label placebo healing intervention

    Communications Biology · November 6, 2025 3 comments on PubPeer (opens in new tab)

  9. Mindful energy balance exercise protocol as an adjunctive intervention for pediatric tourette syndrome: A randomized controlled trial.

    Scientific Reports · October 23, 2025 1 comment on PubPeer (opens in new tab)

  10. Effect of intraoperative low-dose esketamine on postoperative quality of recovery in patients undergoing laparotomy for gynecologic malignancy: a randomized controlled trial

    International Journal of Surgery · September 23, 2025 1 comment on PubPeer (opens in new tab)

  11. Breath-Focused Mindfulness and Compassion Training in Parent-Child Dyads: Pilot Intervention Study.

    JMIR Formative Research · July 17, 2025 1 comment on PubPeer (opens in new tab)

  12. A systematic review of mindfulness-based interventions to reduce ICU nurse burnout: global evidence and thematic synthesis.

    BMC Nursing · July 15, 2025 1 comment on PubPeer (opens in new tab)

  13. Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study.

    Journal of Affective Disorders · June 9, 2025 1 comment on PubPeer (opens in new tab)

  14. Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles.

    Nature Neuroscience · June 1, 2025 1 comment on PubPeer (opens in new tab)

  15. A multi-institutional investigation of psilocybin’s effects on mouse behavior

    bioRxiv (Cold Spring Harbor Laboratory) · April 9, 2025 1 comment on PubPeer (opens in new tab)

  16. RETRACTED ARTICLE: A Review on Meditation: History, Transcendental Dimensions and Application in Psychology and Psychotherapy

    Journal of Contemporary Psychotherapy · February 6, 2025 1 comment on PubPeer (opens in new tab)

  17. Research on the application effect of self-transcendence nursing model in patients with gestational diabetes mellitus: a randomised controlled trial.

    BMC Pregnancy and Childbirth · January 25, 2025 2 comments on PubPeer (opens in new tab)

  18. The impact of mindfulness training on emotional resilience and job engagement among NICU and PICU Saudi and Egyptian nurses: a quasi experimental comparative study.

    Frontiers in Psychiatry · 2025 2 comments on PubPeer (opens in new tab)

  19. Candidate genes related to spiritual mediumship: a whole-exome sequencing analysis of highly gifted mediums.

    Revista Brasileira de Psiquiatria · 2025 1 comment on PubPeer (opens in new tab)

  20. Focused Bodywork as Facilitated Communication: Cautionary Perspectives on Touch in Psychedelic Therapy

    The American Journal of Bioethics · 2025 1 comment on PubPeer (opens in new tab)

  21. Navigating the mainstreaming of psychedelics

    Journal of Psychedelic Studies · 2025 2 comments on PubPeer (opens in new tab)

  22. A quantum microtubule substrate of consciousness is experimentally supported and solves the binding and epiphenomenalism problems.

    Neuroscience of Consciousness · 2025 25 comments on PubPeer (opens in new tab)

  23. Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.

    Frontiers in Psychiatry · 2025 3 comments on PubPeer (opens in new tab)

  24. Is mindfulness practice "at risk" of increasing spirituality? Systematic review and critical analysis of a claimed effect.

    L'Encephale · August 1, 2024 2 comments on PubPeer (opens in new tab)

  25. Dynamic regulation of phosphorylation of NMDA receptor GluN2B subunit tyrosine residues mediates ketamine rapid antidepressant effects.

    Pharmacological Research · July 1, 2024 3 comments on PubPeer (opens in new tab)

  26. A meta-analysis of the effects of ketamine on suicidal ideation in depression patients.

    Translational Psychiatry · June 10, 2024 1 comment on PubPeer (opens in new tab)

  27. Pharmacological and behavioural effects of tryptamines present in psilocybin‐containing mushrooms

    British Journal of Pharmacology · June 2, 2024 1 comment on PubPeer (opens in new tab)

  28. Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial.

    BMC Psychiatry · May 7, 2024 3 comments on PubPeer (opens in new tab)

  29. The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis.

    Journal of Psychopharmacology · May 1, 2024 1 comment on PubPeer (opens in new tab)

  30. Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis

    BMJ · May 1, 2024 2 comments on PubPeer (opens in new tab)

  31. Changes in information integration and brain networks during propofol-, dexmedetomidine-, and ketamine-induced unresponsiveness.

    British Journal of Anaesthesia · March 1, 2024 1 comment on PubPeer (opens in new tab)

  32. Effect of mindfulness-based stress reduction (MBSR) program on depression, emotion regulation, and sleep problems: A randomized controlled trial study on depressed elderly.

    BMC Public Health · January 23, 2024 2 comments on PubPeer (opens in new tab)

  33. Quantum concepts in Psychology: Exploring the interplay of physics and the human psyche.

    Biosystems · 2024 1 comment on PubPeer (opens in new tab)

  34. Psilocybin‐assisted group therapy in patients with cancer diagnosed with a major depressive disorder

    Cancer · December 18, 2023 3 comments on PubPeer (opens in new tab)

  35. The effect of mindfulness meditation on dental anxiety during implant surgery: a randomized controlled clinical trial

    Scientific Reports · December 7, 2023 1 comment on PubPeer (opens in new tab)

  36. Mindfulness-based randomized controlled trials led to brain structural changes: an anatomical likelihood meta-analysis.

    Scientific Reports · October 27, 2023 3 comments on PubPeer (opens in new tab)

  37. Psychedelics reopen the social reward learning critical period

    Nature · June 14, 2023 3 comments on PubPeer (opens in new tab)

  38. Meditation and Its Mental and Physical Health Benefits in 2023.

    Cureus · June 1, 2023 1 comment on PubPeer (opens in new tab)

  39. Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis

    Cureus · May 7, 2023 1 comment on PubPeer (opens in new tab)

  40. Withania somnifera influences MDMA-induced hyperthermic, cognitive, neurotoxic and neuroinflammatory effects in mice.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · May 1, 2023 1 comment on PubPeer (opens in new tab)

  41. Potential Therapeutic Effects of Psilocybin: A Systematic Review.

    Cureus · October 1, 2022 2 comments on PubPeer (opens in new tab)

  42. Who uses digital drugs? An international survey of 'binaural beat' consumers.

    Drug and Alcohol Review · July 1, 2022 1 comment on PubPeer (opens in new tab)

  43. Guanosine boosts the fast, but not sustained, antidepressant-like and pro-synaptogenic effects of ketamine by stimulating mTORC1-driven signaling pathway.

    European Neuropsychopharmacology · January 7, 2022 2 comments on PubPeer (opens in new tab)

  44. Enhanced Interplay of Neuronal Coherence and Coupling in the Dying Human Brain.

    Frontiers in Aging Neuroscience · 2022 1 comment on PubPeer (opens in new tab)

  45. Effects of "Mindfulness Acceptance Insight Commitment" Training on Flow State and Mental Health of College Swimmers: A Randomized Controlled Experimental Study.

    Frontiers in Psychology · 2022 2 comments on PubPeer (opens in new tab)

  46. The resilient phenotype elicited by ketamine against inflammatory stressors-induced depressive-like behavior is associated with NLRP3-driven signaling pathway.

    Journal of Psychiatric Research · September 30, 2021 1 comment on PubPeer (opens in new tab)

  47. Real-time dialogue between experimenters and dreamers during REM sleep.

    Current Biology · April 12, 2021 1 comment on PubPeer (opens in new tab)

  48. The Open Mind: A Phenomenology

    Open Journal of Philosophy · 2021 1 comment on PubPeer (opens in new tab)

  49. Rapid and long-lasting antidepressant-like effects of ketamine and their relationship with the expression of brain enzymes, BDNF, and astrocytes

    Brazilian Journal of Medical and Biological Research · December 18, 2020 2 comments on PubPeer (opens in new tab)

  50. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

    JAMA Psychiatry · November 4, 2020 1 comment on PubPeer (opens in new tab)

  51. Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)

    The International Journal of Neuropsychopharmacology · August 26, 2020 1 comment on PubPeer (opens in new tab)

  52. Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder

    Journal of Traumatic Stress · February 19, 2020 1 comment on PubPeer (opens in new tab)

  53. Loving-kindness meditation slows biological aging in novices: Evidence from a 12-week randomized controlled trial.

    Psychoneuroendocrinology · October 1, 2019 4 comments on PubPeer (opens in new tab)

  54. 25C-NBOMe, a Novel Designer Psychedelic, Induces Neurotoxicity 50 Times More Potent Than Methamphetamine In Vitro.

    Neurotoxicity Research · May 1, 2019 1 comment on PubPeer (opens in new tab)

  55. Oxytocin-dependent reopening of a social reward learning critical period with MDMA

    Nature · April 3, 2019 3 comments on PubPeer (opens in new tab)

  56. Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy

    Journal of Psychoactive Drugs · March 15, 2019 1 comment on PubPeer (opens in new tab)

  57. MDMA Increases Cooperation and Recruitment of Social Brain Areas When Playing Trustworthy Players in an Iterated Prisoner's Dilemma

    Journal of Neuroscience · November 19, 2018 1 comment on PubPeer (opens in new tab)

  58. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor

    Elife · October 25, 2018 1 comment on PubPeer (opens in new tab)

  59. Mindfulness Meditation Reduces Intraocular Pressure, Lowers Stress Biomarkers and Modulates Gene Expression in Glaucoma: A Randomized Controlled Trial

    Journal of glaucoma · September 25, 2018 1 comment on PubPeer (opens in new tab)

  60. Impairment of perceptual metacognitive accuracy and reduced prefrontal grey matter volume in first-episode psychosis

    Cognitive Neuropsychiatry · February 27, 2018 1 comment on PubPeer (opens in new tab)

  61. The Projective Consciousness Model and Phenomenal Selfhood.

    Frontiers in Psychology · 2018 1 comment on PubPeer (opens in new tab)

  62. Towards solving the hard problem of consciousness: The varieties of brain resonances and the conscious experiences that they support.

    Neural Networks · March 1, 2017 5 comments on PubPeer (opens in new tab)

  63. Conscious Vision Proceeds from Global to Local Content in Goal-Directed Tasks and Spontaneous Vision.

    Journal of Neuroscience · May 11, 2016 1 comment on PubPeer (opens in new tab)

  64. Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans.

    Journal of Psychopharmacology · April 1, 2016 1 comment on PubPeer (opens in new tab)

  65. Meditation training influences mind wandering and mindless reading.

    Psychology of Consciousness Theory Research and Practice · March 1, 2016 1 comment on PubPeer (opens in new tab)

  66. A training programme involving automatic self-transcending meditation in late-life depression: preliminary analysis of an ongoing randomised controlled trial

    BJPsych Open · March 1, 2016 1 comment on PubPeer (opens in new tab)

  67. Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide

    Journal of Psychopharmacology · 2016 1 comment on PubPeer (opens in new tab)

  68. Noribogaine is a G-protein biased κ-opioid receptor agonist.

    Neuropharmacology · December 1, 2015 2 comments on PubPeer (opens in new tab)

  69. The Body Scan and Mindful Breathing Among Veterans with PTSD: Type of Intervention Moderates the Relationship Between Changes in Mindfulness and Post-treatment Depression.

    Mindfulness · October 20, 2015 1 comment on PubPeer (opens in new tab)

  70. Feeling the future: A meta-analysis of 90 experiments on the anomalous anticipation of random future events [version 1; referees: 2 approved]

    DOAJ (DOAJ: Directory of Open Access Journals) · October 1, 2015 3 comments on PubPeer (opens in new tab)

  71. 3,4-Methylenedioxymethamphetamine facilitates fear extinction learning

    Translational Psychiatry · September 15, 2015 1 comment on PubPeer (opens in new tab)

  72. R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects

    Translational Psychiatry · September 1, 2015 3 comments on PubPeer (opens in new tab)

  73. Mindfulness-Based Cognitive Therapy (MBCT) Reduces the Association Between Depressive Symptoms and Suicidal Cognitions in Patients With a History of Suicidal Depression

    Journal of Consulting and Clinical Psychology · August 24, 2015 1 comment on PubPeer (opens in new tab)

  74. Altered subjective reward valuation among drug-deprived heavy marijuana users: Aversion to uncertainty

    Journal of Abnormal Psychology · August 6, 2015 1 comment on PubPeer (opens in new tab)

  75. Development of the Sources of Spirituality Scale.

    Journal of Counseling Psychology · July 1, 2015 1 comment on PubPeer (opens in new tab)

  76. Physical Activity, Mindfulness Meditation, or Heart Rate Variability Biofeedback for Stress Reduction: A Randomized Controlled Trial

    Applied Psychophysiology and Biofeedback · June 25, 2015 2 comments on PubPeer (opens in new tab)

  77. Noribogaine reduces nicotine self-administration in rats.

    Journal of Psychopharmacology · June 1, 2015 2 comments on PubPeer (opens in new tab)

  78. Recreational 3,4-methylenedioxy-N-methylamphetamine (MDMA) or ‘ecstasy’ and self-focused compassion: Preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices

    Journal of Psychopharmacology · May 18, 2015 1 comment on PubPeer (opens in new tab)

  79. Mindfulness and Metta-based Trauma Therapy (MMTT): Initial Development and Proof-of-Concept of an Internet Resource

    Mindfulness · April 8, 2015 1 comment on PubPeer (opens in new tab)

  80. Mindfulness Meditation Reduces Implicit Age and Race Bias

    Social Psychological and Personality Science · November 24, 2014 1 comment on PubPeer (opens in new tab)

  81. LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects

    Journal of Psychopharmacology · November 11, 2014 1 comment on PubPeer (opens in new tab)

  82. Domain-specific enhancement of metacognitive ability following meditation training.

    Journal of Experimental Psychology General · October 1, 2014 1 comment on PubPeer (opens in new tab)

  83. We see more than we can report: "cost free" color phenomenality outside focal attention.

    Psychological Science · July 1, 2014 1 comment on PubPeer (opens in new tab)

  84. Methodological concerns for meta-analyses of meditation: Comment on Sedlmeier et al. (2012).

    Psychological Bulletin · March 1, 2014 1 comment on PubPeer (opens in new tab)

  85. The secret ingredient in mindfulness interventions? A case for practice quality over quantity.

    Journal of Counseling Psychology · 2014 1 comment on PubPeer (opens in new tab)

  86. Debiasing the Mind Through Meditation

    Psychological Science · December 6, 2013 1 comment on PubPeer (opens in new tab)

  87. Mindfulness-based cognitive therapy for preventing relapse in recurrent depression: A randomized dismantling trial.

    Journal of Consulting and Clinical Psychology · December 3, 2013 1 comment on PubPeer (opens in new tab)

  88. Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

    American Journal of Psychiatry · August 28, 2013 3 comments on PubPeer (opens in new tab)

  89. How positive emotions build physical health: perceived positive social connections account for the upward spiral between positive emotions and vagal tone.

    Psychological Science · July 1, 2013 1 comment on PubPeer (opens in new tab)

  90. Mindfulness Training Improves Working Memory Capacity and GRE Performance While Reducing Mind Wandering

    Psychological Science · March 28, 2013 1 comment on PubPeer (opens in new tab)

  91. Treatment-specific changes in decentering following mindfulness-based cognitive therapy versus antidepressant medication or placebo for prevention of depressive relapse.

    Journal of Consulting and Clinical Psychology · March 12, 2012 1 comment on PubPeer (opens in new tab)

  92. Mindfulness and mind-wandering: Finding convergence through opposing constructs.

    Emotion · February 6, 2012 1 comment on PubPeer (opens in new tab)

  93. Daily stress interacts with trait dissociation to predict sleep-related experiences in young adults.

    Journal of Abnormal Psychology · August 1, 2011 1 comment on PubPeer (opens in new tab)

  94. On the Relationship Between the Practice of Mindfulness Meditation and Personality-an Exploratory Analysis of the Mediating Role of Mindfulness Skills.

    Mindfulness · June 18, 2011 1 comment on PubPeer (opens in new tab)

  95. The A2a adenosine receptor modulates the reinforcement efficacy and neurotoxicity of MDMA

    Journal of Psychopharmacology · January 24, 2011 1 comment on PubPeer (opens in new tab)

  96. Assessing adolescent mindfulness: Validation of an Adapted Mindful Attention Awareness Scale in adolescent normative and psychiatric populations.

    Psychological Assessment · 2011 1 comment on PubPeer (opens in new tab)

  97. Dispositional Mindfulness, Meditation, and Conditional Goal Setting.

    Mindfulness · December 1, 2010 1 comment on PubPeer (opens in new tab)

  98. Behavioral profiles in rats distinguish among "ecstasy," methamphetamine and 2,5-dimethoxy-4-iodoamphetamine: Mixed effects for "ecstasy" analogues.

    Behavioral Neuroscience · October 1, 2010 1 comment on PubPeer (opens in new tab)

  99. mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

    Science · August 19, 2010 1 comment on PubPeer (opens in new tab)

  100. Being present in the face of existential threat: The role of trait mindfulness in reducing defensive responses to mortality salience.

    Journal of Personality and Social Psychology · July 26, 2010 1 comment on PubPeer (opens in new tab)

  101. Dissociative symptoms and reported trauma among patients with spirit possession and matched healthy controls in Uganda.

    Culture, Medicine, and Psychiatry · June 1, 2010 1 comment on PubPeer (opens in new tab)

  102. Effects of mindfulness on meta-awareness and specificity of describing prodromal symptoms in suicidal depression.

    Emotion · February 1, 2010 1 comment on PubPeer (opens in new tab)

  103. Minding one’s emotions: Mindfulness training alters the neural expression of sadness.

    Emotion · February 1, 2010 1 comment on PubPeer (opens in new tab)

  104. Cortical thickness and pain sensitivity in zen meditators.

    Emotion · February 1, 2010 1 comment on PubPeer (opens in new tab)

  105. Effects of Mindfulness-Based Stress Reduction (MBSR) on Emotion Regulation in Social Anxiety Disorder

    Emotion · February 1, 2010 1 comment on PubPeer (opens in new tab)

  106. Dispositional mindfulness and depressive symptomatology: Correlations with limbic and self-referential neural activity during rest.

    Emotion · 2010 1 comment on PubPeer (opens in new tab)

  107. Psychedelics and the Human Receptorome

    PLoS One · 2010 2 comments on PubPeer (opens in new tab)

  108. Adaptation of imagery rehearsal therapy for nightmares in children: A brief report.

    Psychotherapy · December 1, 2009 1 comment on PubPeer (opens in new tab)

  109. MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning.

    Behavioral Neuroscience · October 1, 2009 1 comment on PubPeer (opens in new tab)

  110. Mindfulness-Based Stress Reduction for Stress Management in Healthy People: A Review and Meta-Analysis

    The Journal of Alternative and Complementary Medicine · May 1, 2009 1 comment on PubPeer (opens in new tab)

  111. Lost in the Sauce

    Psychological Science · April 28, 2009 1 comment on PubPeer (opens in new tab)

  112. Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources.

    Journal of Personality and Social Psychology · October 27, 2008 1 comment on PubPeer (opens in new tab)

  113. Effects of Mindfulness-Based Stress Reduction Intervention on Psychological Well-being and Quality of Life: Is Increased Mindfulness Indeed the Mechanism?

    Annals of Behavioral Medicine · June 1, 2008 1 comment on PubPeer (opens in new tab)

  114. Mindfulness meditation and substance use in an incarcerated population.

    Psychology of Addictive Behaviors · August 28, 2006 1 comment on PubPeer (opens in new tab)

  115. Attenuation of the disruptive effects of (+/-)3,4-methylene dioxymethamphetamine (MDMA) on delayed matching-to-sample performance in the rat.

    Behavioral Neuroscience · 2006 1 comment on PubPeer (opens in new tab)

  116. Syllogistic Reasoning Performance in MDMA (Ecstasy) Users.

    Experimental and Clinical Psychopharmacology · 2005 1 comment on PubPeer (opens in new tab)

  117. The benefits of being present: Mindfulness and its role in psychological well-being.

    Journal of Personality and Social Psychology · 2003 1 comment on PubPeer (opens in new tab)

Statuses come from Crossref's retraction and update records, which include the Retraction Watch database, and from PubPeer. A paper can carry a notice we have not picked up yet, so treat this as the best record we have rather than a complete one. If you spot something missing, get in touch.